All Stories

  1. Effect of Dapagliflozin in DAPA-HF According to Background Glucose-Lowering Therapy

    Article • Diabetes Care, September 2020, American Diabetes Association

    Professor john j mcmurray

  2. The Dapagliflozin And Prevention of Adverse outcomes in Heart Failure trial (DAPA-HF) in context

    Article • European Heart Journal, January 2020, Oxford University Press (OUP)

    Professor john j mcmurray

  3. PIONEER-HF: a new frontier in the role of neprilysin inhibition in the management of heart failure with reduced ejection fraction

    Article • Cardiovascular Research, September 2019, Oxford University Press (OUP)

    Professor john j mcmurray

  4. Retinopathy, Neuropathy, and Subsequent Cardiovascular Events in Patients with Type 2 Diabetes and Acute Coronary Syndrome in the ELIXA: The Importance of Disease Duration

    Article • Journal of Diabetes Research, December 2018, Hindawi Publishing Corporation

    Professor john j mcmurray, MD Aldo P Maggioni

  5. Anticoagulation, atherothrombosis, and heart failure: lessons from COMMANDER-HF and CORONA

    Article • European Heart Journal, October 2018, Oxford University Press (OUP)

    Professor john j mcmurray

  6. Initiation of domiciliary care and nursing home admission following first hospitalization of heart failure patients: a nationwide cohort study

    Article • Clinical Epidemiology, August 2018, Dove Medical Press

    Professor john j mcmurray, Dr Søren Lund Kristensen

  7. NT-proBNP predicts the cardio-renal response to aliskiren in patients with type 2 diabetes at high renal and cardiovascular risk

    Article • Diabetes Obesity and Metabolism, July 2018, Wiley

    Professor john j mcmurray, Dr Frederik Persson

  8. Risk of Incident Heart Failure in Patients With Diabetes and Asymptomatic Left Ventricular Systolic Dysfunction

    Article • Diabetes Care, April 2018, American Diabetes Association

    Professor john j mcmurray

  9. Baseline characteristics and enrichment results of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial

    Article • Diabetes Obesity and Metabolism, March 2018, Wiley

    Professor john j mcmurray

  10. Multimorbidity in patients with heart failure from 11 Asian regions: A prospective cohort study using the ASIAN-HF registry

    Article • PLoS Medicine, March 2018, PLOS

    Professor john j mcmurray

  11. Why do SGLT2 inhibitors reduce heart failure hospitalization? A differential volume regulation hypothesis

    Article • Diabetes Obesity and Metabolism, November 2017, Wiley

    Professor john j mcmurray

  12. Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease—Improving Global Outcomes (KDIGO) Controversies Conference

    Article • Kidney International, August 2017, Elsevier

    Professor john j mcmurray

  13. Re-Examination of the BEST Trial Using Composite Outcomes, Including Emergency Department Visits

    Article • JACC Heart Failure, August 2017, Elsevier

    Professor john j mcmurray

  14. Declining Risk of Sudden Death in Heart Failure

    Article • New England Journal of Medicine, July 2017, New England Journal of Medicine (NEJM/MMS)

    Professor john j mcmurray

  15. Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction

    Article • JACC Heart Failure, July 2017, Elsevier

    Professor john j mcmurray

  16. Cost-Effectiveness Analysis of Natriuretic Peptide Testing and Specialist Management in Patients with Suspected Acute Heart Failure

    Article • Value in Health, July 2017, Elsevier

    Professor john j mcmurray

  17. The Metabolodiuretic Promise of Sodium-Dependent Glucose Cotransporter 2 Inhibition

    Article • JAMA Cardiology, June 2017, American Medical Association (AMA)

    Professor john j mcmurray

  18. Cognitive Impairment and Heart Failure: Systematic Review and Meta-Analysis

    Article • Journal of Cardiac Failure, June 2017, Elsevier

    Professor john j mcmurray

  19. The effects of sacubitril/valsartan on coronary outcomes in PARADIGM-HF

    Article • American Heart Journal, June 2017, Elsevier

    Professor john j mcmurray, Professor Vladimir V Rafalskiy

  20. ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD

    Article • American Journal of Kidney Diseases, June 2017, Elsevier

    Professor john j mcmurray

  21. Dynamic changes and prognostic value of pulmonary congestion by lung ultrasound in acute and chronic heart failure: a systematic review

    Article • European Journal of Heart Failure, May 2017, Wiley

    Professor john j mcmurray

  22. Role of B‐Type Natriuretic Peptide and N‐Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus

    Article • Journal of the American Heart Association, May 2017, Wolters Kluwer Health

    Professor john j mcmurray

  23. Seasonal variations in cardiovascular disease

    Article • Nature Reviews Cardiology, May 2017, Nature

    Professor john j mcmurray

  24. Effect of Apixaban on All-Cause Death in Patients with Atrial Fibrillation: a Meta-Analysis Based on Imputed Placebo Effect

    Article • Cardiovascular Drugs and Therapy, May 2017, Springer Science + Business Media

    Professor john j mcmurray

  25. Effect of Ularitide on Cardiovascular Mortality in Acute Heart Failure

    Article • New England Journal of Medicine, May 2017, New England Journal of Medicine (NEJM/MMS)

    Professor john j mcmurray

  26. Updated risk factors should be used to predict development of diabetes

    Article • Journal of Diabetes and its Complications, May 2017, Elsevier

    Professor john j mcmurray

  27. Importance of endogenous compensatory vasoactive peptides in broadening the effects of inhibitors of the renin-angiotensin system for the treatment of heart failure

    Article • The Lancet, May 2017, Elsevier

    Professor john j mcmurray

  28. Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial

    Article • The Lancet Diabetes & Endocrinology, May 2017, Elsevier

    Professor john j mcmurray

  29. Long-Term Effect of Endothelin Receptor Antagonism With Bosentan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure

    Article • JACC Heart Failure, May 2017, Elsevier

    Professor john j mcmurray

  30. The Design of the Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Trial

    Article • American Heart Journal, May 2017, Elsevier

    Professor john j mcmurray

  31. Expert consensus document: Echocardiography and lung ultrasonography for the assessment and management of acute heart failure

    Article • Nature Reviews Cardiology, April 2017, Nature

    Professor john j mcmurray, Prof HECTOR BUENO

  32. Limited Added Value of Circulating Inflammatory Biomarkers in Chronic Heart Failure

    Article • JACC Heart Failure, April 2017, Elsevier

    Professor john j mcmurray

  33. New medicinal products for chronic heart failure: advances in clinical trial design and efficacy assessment

    Article • European Journal of Heart Failure, March 2017, Wiley

    Professor john j mcmurray

  34. Effect of valsartan on kidney outcomes in people with impaired glucose tolerance

    Article • Diabetes Obesity and Metabolism, March 2017, Wiley

    Professor john j mcmurray

  35. Measurement of troponin and natriuretic peptides shortly after admission in patients with heart failure-does it add useful prognostic information? An analysis of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Studies (V

    Article • European Journal of Heart Failure, March 2017, Wiley

    Professor john j mcmurray

  36. Effect of eplerenone in patients with heart failure and reduced ejection fraction: potential effect modification by abdominal obesity

    Article • European Journal of Heart Failure, March 2017, Wiley

    Professor john j mcmurray

  37. Serum Chloride and Sodium Interplay in Patients With Acute Myocardial Infarction and Heart Failure With Reduced Ejection FractionCLINICAL PERSPECTIVE

    Article • Circulation Heart Failure, February 2017, Wolters Kluwer Health

    Dr Joao Pedro Ferreira, Professor john j mcmurray

  38. Referral for Specialist Follow-up and Its Association With Post-discharge Mortality Among Patients With Systolic Heart Failure (from the National Heart Failure Audit for England and Wales)

    Article • The American Journal of Cardiology, February 2017, Elsevier

    Professor john j mcmurray

  39. Renin–Angiotensin System Inhibition, Worsening Renal Function, and Outcome in Heart Failure Patients With Reduced and Preserved Ejection FractionCLINICAL PERSPECTIVE

    Article • Circulation Heart Failure, February 2017, Wolters Kluwer Health

    Professor john j mcmurray

  40. Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril/valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: results from PARADIGM-HF

    Article • European Heart Journal, February 2017, Oxford University Press (OUP)

    Michael Böhm, Professor john j mcmurray

  41. Clinical Trials Involving Hypertension

    Article • New England Journal of Medicine, January 2017, New England Journal of Medicine (NEJM/MMS)

    Professor john j mcmurray

  42. B-type natriuretic peptides in chronic obstructive pulmonary disease: a systematic review

    Article • BMC Pulmonary Medicine, January 2017, Springer Science + Business Media

    Professor john j mcmurray

  43. Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection FractionClinical Perspective

    Article • Circulation, January 2017, Wolters Kluwer Health

    Professor john j mcmurray

  44. Aldosterone Does Not Predict Cardiovascular Events Following Acute Coronary Syndrome in Patients Initially Without Heart Failure

    Article • Journal of the American Heart Association, January 2017, Wolters Kluwer Health

    Professor john j mcmurray

  45. Guía ESC 2016 sobre el diagnóstico y tratamiento de la fibrilación auricular, desarrollada en colaboración con la EACTS

    Article • Revista Española de Cardiología, January 2017, Elsevier

    Professor john j mcmurray, Professor Antonis S Manolis

  46. International Variation in Outcomes Among People with Cardiovascular Disease or Cardiovascular Risk Factors and Impaired Glucose Tolerance: Insights from the NAVIGATOR Trial

    Article • Journal of the American Heart Association, January 2017, Wolters Kluwer Health

    Professor john j mcmurray

  47. Thirty Years of Evidence on the Efficacy of Drug Treatments for Chronic Heart Failure With Reduced Ejection FractionCLINICAL PERSPECTIVE

    Article • Circulation Heart Failure, January 2017, Wolters Kluwer Health

    Professor john j mcmurray

  48. Prognostic Value of Insulin-Like Growth Factor-Binding Protein 7 in Patients with Heart Failure and Preserved Ejection Fraction

    Article • Journal of Cardiac Failure, January 2017, Elsevier

    Professor john j mcmurray

  49. C-Reactive Protein and Risk of ESRD: Results From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)

    Article • American Journal of Kidney Diseases, December 2016, Elsevier

    Professor john j mcmurray

  50. Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial

    Article • The Lancet, December 2016, Elsevier

    Professor john j mcmurray

  51. Guía ESC 2016 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica

    Article • Revista Española de Cardiología, December 2016, Elsevier

    Professor john j mcmurray, Prof HECTOR BUENO

  52. Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure

    Article • Journal of the American College of Cardiology, December 2016, Elsevier

    Professor john j mcmurray

  53. Treatment With Dalcetrapib Modifies the Relationship Between High-Density Lipoprotein Cholesterol and C-Reactive Protein

    Article • Journal of the American College of Cardiology, December 2016, Elsevier

    Professor john j mcmurray

  54. Impact of Body Mass Index on the Accuracy of N-Terminal Pro-Brain Natriuretic Peptide and Brain Natriuretic Peptide for Predicting Outcomes in Patients With Chronic Heart Failure and Reduced Ejection Fraction

    Article • Circulation, November 2016, Wolters Kluwer Health

    Professor john j mcmurray

  55. Dementia-related adverse events in PARADIGM-HF and other trials in heart failure with reduced ejection fraction

    Article • European Journal of Heart Failure, November 2016, Wiley

    Professor Vladimir V Rafalskiy, Professor john j mcmurray

  56. Impact of eplerenone on cardiovascular outcomes in heart failure patients with hypokalaemia

    Article • European Journal of Heart Failure, November 2016, Wiley

    Professor john j mcmurray

  57. Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials

    Article • European Heart Journal, November 2016, European Society of Cardiology

    Professor john j mcmurray

  58. Rationale for and design of the TRUE-AHF trial: the effects of ularitide on the short-term clinical course and long-term mortality of patients with acute heart failure

    Article • European Journal of Heart Failure, November 2016, Wiley

    Professor john j mcmurray

  59. Renal function estimation and Cockcroft–Gault formulas for predicting cardiovascular mortality in population-based, cardiovascular risk, heart failure and post-myocardial infarction cohorts: The Heart ‘OMics’ in AGEing (HOMAGE) and the high-risk myocar...

    Article • BMC Medicine, November 2016, Springer Science + Business Media

    Dr Pierpaolo Pellicori, Professor john j mcmurray

  60. Lessons in Uncertainty and Humility — Clinical Trials Involving Hypertension

    Article • New England Journal of Medicine, November 2016, New England Journal of Medicine (NEJM/MMS)

    Professor john j mcmurray

  61. Practical approach on frail older patients attended for acute heart failure

    Article • International Journal of Cardiology, November 2016, Elsevier

    Prof HECTOR BUENO, Professor john j mcmurray

  62. Efficacy and Safety of Novel Oral Anticoagulants in Patients With Atrial Fibrillation and Heart Failure

    Article • JACC Heart Failure, November 2016, Elsevier

    Professor john j mcmurray

  63. How robust are clinical trials in heart failure?

    Article • European Heart Journal, October 2016, European Society of Cardiology

    Professor john j mcmurray

  64. Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib: the Standard care vs. Celecoxib Outcome Trial (SCOT)

    Article • European Heart Journal, October 2016, European Society of Cardiology

    Professor john j mcmurray

  65. Efficacy of Sacubitril/Valsartan Relative to a Prior Decompensation

    Article • JACC Heart Failure, October 2016, Elsevier

    Professor john j mcmurray

  66. Predictors and Associations With Outcomes of Length of Hospital Stay in Patients With Acute Heart Failure: Results From VERITAS

    Article • Journal of Cardiac Failure, October 2016, Elsevier

    Professor john j mcmurray, Professor John GF Cleland

  67. The ICD in Heart Failure — Time for a Rethink?

    Article • New England Journal of Medicine, September 2016, New England Journal of Medicine (NEJM/MMS)

    Professor john j mcmurray

  68. European Society of Cardiology-Acute Cardiovascular Care Association Position paper on acute heart failure: A call for interdisciplinary care

    Article • European Heart Journal Acute Cardiovascular Care, September 2016, SAGE Publications

    Prof HECTOR BUENO, Professor john j mcmurray

  69. Insufficient reduction in heart rate during hospitalization despite beta-blocker treatment in acute decompensated heart failure: insights from the ASCEND-HF trial

    Article • European Journal of Heart Failure, September 2016, Wiley

    Professor john j mcmurray

  70. Site Selection and Performance in Clinical Trials

    Article • Circulation Heart Failure, September 2016, Wolters Kluwer Health

    Professor john j mcmurray

  71. Effects of Sacubitril/Valsartan in the PARADIGM-HF Trial (Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure) According to Background TherapyCLINICAL PERSPECTIVE

    Article • Circulation Heart Failure, September 2016, Wolters Kluwer Health

    Professor john j mcmurray, Professor Vladimir V Rafalskiy

  72. Severity of renal impairment in patients with heart failure and atrial fibrillation: implications for non-vitamin K antagonist oral anticoagulant dose adjustment

    Article • European Journal of Heart Failure, September 2016, Wiley

    Professor john j mcmurray

  73. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

    Article • European Heart Journal, August 2016, European Society of Cardiology

    Professor john j mcmurray, Professor Tchavdar N Shalganov, Prof HECTOR BUENO, Professor Antonis S Manolis, Professor Erkin Mirrakhimov

  74. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

    Article • EP Europace, August 2016, European Society of Cardiology

    Professor john j mcmurray, Professor Antonis S Manolis

  75. Aliskiren, Enalapril, or Both in Heart Failure

    Article • New England Journal of Medicine, August 2016, New England Journal of Medicine (NEJM/MMS)

    Professor john j mcmurray

  76. Variation in hospital performance for heart failure management in the National Heart Failure Audit for England and Wales

    Article • Heart, August 2016, BMJ

    Professor john j mcmurray

  77. Return to the Workforce After First Hospitalization for Heart FailureClinical Perspective

    Article • Circulation, August 2016, Wolters Kluwer Health

    Professor john j mcmurray

  78. Worsening renal function and outcome in heart failure patients with reduced and preserved ejection fraction and the impact of angiotensin receptor blocker treatment: data from the CHARM-study programme

    Article • European Journal of Heart Failure, July 2016, Wiley

    Professor john j mcmurray

  79. Low YKL-40 in chronic heart failure may predict beneficial effects of statins: analysis from the controlled rosuvastatin multinational trial in heart failure (CORONA)

    Article • Biomarkers, July 2016, Taylor & Francis

    Professor john j mcmurray

  80. End of the Road for Vagus Nerve Stimulation?∗

    Article • Journal of the American College of Cardiology, July 2016, Elsevier

    Professor john j mcmurray

  81. Influence of Sacubitril/Valsartan (LCZ696) on 30-Day Readmission After Heart Failure Hospitalization

    Article • Journal of the American College of Cardiology, July 2016, Elsevier

    Professor john j mcmurray, Professor Vladimir V Rafalskiy

  82. Combined neprilysin and renin-angiotensin system inhibition in heart failure with reduced ejection fraction: a meta-analysis

    Article • European Journal of Heart Failure, June 2016, Wiley

    Professor john j mcmurray

  83. Geographic variations in the PARADIGM-HF heart failure trial

    Article • European Heart Journal, June 2016, European Society of Cardiology

    Professor john j mcmurray

  84. Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM-HF trial

    Article • European Journal of Heart Failure, June 2016, Wiley

    Professor john j mcmurray

  85. Clinical Trials Series

    Article • New England Journal of Medicine, June 2016, New England Journal of Medicine (NEJM/MMS)

    Professor john j mcmurray

  86. Dichotomous Relationship Between Age and 30-Day Death or Rehospitalization in Heart Failure Patients Admitted With Acute Decompensated Heart Failure: Results From the ASCEND-HF Trial

    Article • Journal of Cardiac Failure, June 2016, Elsevier

    Professor john j mcmurray

  87. Factors Associated With Noncompletion During the Run-In Period Before Randomization and Influence on the Estimated Benefit of LCZ696 in the PARADIGM-HF TrialCLINICAL PERSPECTIVE

    Article • Circulation Heart Failure, June 2016, Wolters Kluwer Health

    Professor john j mcmurray

  88. Geographic Differences in Patients in a Global Acute Heart Failure Clinical Trial (from the ASCEND-HF Trial)

    Article • The American Journal of Cardiology, June 2016, Elsevier

    Professor john j mcmurray

  89. Predicting Outcomes Over Time in Patients With Heart Failure, Left Ventricular Systolic Dysfunction, or Both Following Acute Myocardial Infarction

    Article • Journal of the American Heart Association, June 2016, Wolters Kluwer Health

    Professor john j mcmurray

  90. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

    Article • European Journal of Heart Failure, May 2016, Wiley

    Prof HECTOR BUENO, Professor john j mcmurray

  91. The neprilysin pathway in heart failure: a review and guide on the use of sacubitril/valsartan

    Article • Heart, May 2016, BMJ

    Professor john j mcmurray

  92. Clinical outcomes according to QRS duration and morphology in the irbesartan in patients with heart failure and preserved systolic function (I-PRESERVE) trial

    Article • European Journal of Heart Failure, May 2016, Wiley

    Professor john j mcmurray

  93. Erratum to: SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?

    Article • Diabetologia, May 2016, Springer Science + Business Media

    Professor john j mcmurray

  94. Initiating sacubitril/valsartan (LCZ696) in heart failure: results of TITRATION, a double-blind, randomized comparison of two uptitration regimens

    Article • European Journal of Heart Failure, May 2016, Wiley

    Professor john j mcmurray

  95. Effect of single and dual renin-angiotensin blockade on stroke in patients with and without diabetes in VALIANT

    Article • European Stroke Journal, May 2016, SAGE Publications

    Professor john j mcmurray

  96. Reporting of Lost to Follow-Up and Treatment Discontinuation in Pharmacotherapy and Device Trials in Chronic Heart FailureCLINICAL PERSPECTIVE

    Article • Circulation Heart Failure, May 2016, Wolters Kluwer Health

    Professor john j mcmurray

  97. SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?

    Article • Diabetologia, April 2016, Springer Science + Business Media

    Professor john j mcmurray

  98. The incremental prognostic and clinical value of multiple novel biomarkers in heart failure

    Article • European Journal of Heart Failure, April 2016, Wiley

    Professor john j mcmurray

  99. Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure

    Article • New England Journal of Medicine, April 2016, New England Journal of Medicine (NEJM/MMS)

    Professor john j mcmurray

  100. Importance of Clinical Worsening of Heart Failure Treated in the Outpatient SettingCLINICAL PERSPECTIVE

    Article • Circulation, April 2016, Wolters Kluwer Health

    Professor Vladimir V Rafalskiy, Professor john j mcmurray

  101. Disease Management Programs in Cardiology

    Article • Circulation, April 2016, Wolters Kluwer Health

    Professor john j mcmurray

  102. Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency

    Article • European Journal of Heart Failure, April 2016, Wiley

    Professor Giuseppe M C Rosano, Professor john j mcmurray

  103. Coronary Artery Disease Is a Predictor of Progression to Dialysis in Patients With Chronic Kidney Disease, Type 2 Diabetes Mellitus, and Anemia: An Analysis of the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)

    Article • Journal of the American Heart Association, April 2016, Wolters Kluwer Health

    Professor john j mcmurray

  104. Efficacy and safety of digoxin in patients with heart failure and reduced ejection fraction according to diabetes status: An analysis of the Digitalis Investigation Group (DIG) trial

    Article • International Journal of Cardiology, April 2016, Elsevier

    Professor john j mcmurray

  105. Renal outcomes with aliskiren in patients with type 2 diabetes: a prespecified secondary analysis of the ALTITUDE randomised controlled trial

    Article • The Lancet Diabetes & Endocrinology, April 2016, Elsevier

    Professor john j mcmurray, Dr Frederik Persson

  106. Trials and the ‘real world’ - how different are they?

    Article • European Journal of Heart Failure, March 2016, Wiley

    Professor john j mcmurray

  107. The McMurray Fire

    Article • Journal of Extreme Events, March 2016, World Scientific Pub Co Pte Lt

    Professor john j mcmurray

  108. Acute Treatment With Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure

    Article • Journal of the American College of Cardiology, March 2016, Elsevier

    Professor john j mcmurray

  109. Influence of Ejection Fraction on Outcomes and Efficacy of Sacubitril/Valsartan (LCZ696) in Heart Failure with Reduced Ejection FractionCLINICAL PERSPECTIVE

    Article • Circulation Heart Failure, February 2016, Wolters Kluwer Health

    Professor john j mcmurray

  110. Aspirin does not reduce the clinical benefits of the mineralocorticoid receptor antagonist eplerenone in patients with systolic heart failure and mild symptoms: an analysis of the EMPHASIS-HF study

    Article • European Journal of Heart Failure, February 2016, Wiley

    Dr Ken Lee Chin, Professor john j mcmurray

  111. Influenza Vaccination in Patients With Chronic Heart Failure

    Article • JACC Heart Failure, February 2016, Elsevier

    Professor john j mcmurray

  112. Is a reduction in albuminuria associated with renal and cardiovascular protection? Apost hocanalysis of the ALTITUDE trial

    Article • Diabetes Obesity and Metabolism, January 2016, Wiley

    Professor john j mcmurray, Dr Frederik Persson

  113. Risk Related to Pre–Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection FractionCLINICAL PERSPECTIVE

    Article • Circulation Heart Failure, January 2016, Wolters Kluwer Health

    Professor Vladimir V Rafalskiy, Professor john j mcmurray

  114. EMPA-REG – the “diuretic hypothesis”

    Article • Journal of Diabetes and its Complications, January 2016, Elsevier

    Professor john j mcmurray

  115. Sacubitril/Valsartan (LCZ696) in Heart Failure

    Article • January 2016, Springer Science + Business Media

    Professor john j mcmurray

  116. Plasma Biomarkers Reflecting Profibrotic Processes in Heart Failure With a Preserved Ejection FractionCLINICAL PERSPECTIVE

    Article • Circulation Heart Failure, January 2016, Wolters Kluwer Health

    Professor john j mcmurray

  117. Prognostic Value of Baseline and Changes in Circulating Soluble ST2 Levels and the Effects of Nesiritide in Acute Decompensated Heart Failure

    Article • JACC Heart Failure, January 2016, Elsevier

    Professor john j mcmurray

  118. Liver function tests in patients with acute heart failure and associated outcomes: insights from ASCEND-HF

    Article • European Journal of Heart Failure, December 2015, Wiley

    Professor john j mcmurray

  119. Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction

    Article • European Journal of Heart Failure, December 2015, Wiley

    Professor john j mcmurray, Professor John GF Cleland

  120. Increased mortality with elevated plasma endothelin-1 in acute heart failure: an ASCEND-HF biomarker substudy

    Article • European Journal of Heart Failure, December 2015, Wiley

    Professor john j mcmurray

  121. Predicting heart failure decompensation using cardiac implantable electronic devices: a review of practices and challenges

    Article • European Journal of Heart Failure, December 2015, Wiley

    Professor john j mcmurray

  122. Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome

    Article • New England Journal of Medicine, December 2015, New England Journal of Medicine (NEJM/MMS)

    Professor Vladimir V Rafalskiy, Professor john j mcmurray

  123. Estimating the Long-Term Treatment Benefits of Sacubitril–Valsartan

    Article • New England Journal of Medicine, December 2015, New England Journal of Medicine (NEJM/MMS)

    Professor john j mcmurray

  124. Statistical Controversies in Reporting of Clinical Trials

    Article • Journal of the American College of Cardiology, December 2015, Elsevier

    Professor john j mcmurray

  125. Making Sense of Statistics in Clinical Trial Reports

    Article • Journal of the American College of Cardiology, December 2015, Elsevier

    Professor john j mcmurray

  126. Response to Letter Regarding Article, “Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopra...

    Article • Circulation, November 2015, Wolters Kluwer Health

    Professor john j mcmurray

  127. Improving outcomes in heart failure: a personal perspective

    Article • European Heart Journal, November 2015, European Society of Cardiology

    Professor john j mcmurray

  128. Regional cardiac dysfunction and outcome in patients with left ventricular dysfunction, heart failure, or both after myocardial infarction

    Article • European Heart Journal, November 2015, European Society of Cardiology

    Professor john j mcmurray

  129. Comparing LCZ696 With Enalapril According to Baseline Risk Using the MAGGIC and EMPHASIS-HF Risk Scores

    Article • Journal of the American College of Cardiology, November 2015, Elsevier

    Professor Vladimir V Rafalskiy, Professor john j mcmurray

  130. The clinical course of health status and association with outcomes in patients hospitalized for heart failure: insights from ASCEND-HF

    Article • European Journal of Heart Failure, October 2015, Wiley

    Dr Robert John Mentz, Professor john j mcmurray

  131. The Aliskiren Trial to Minimize OutcomeS in Patients with HEart failure trial (ATMOSPHERE): revised statistical analysis plan and baseline characteristics

    Article • European Journal of Heart Failure, October 2015, Wiley

    Professor john j mcmurray

  132. Circulating Kidney Injury Molecule-1 Levels in Acute Heart Failure

    Article • JACC Heart Failure, October 2015, Elsevier

    Professor john j mcmurray

  133. Increased risk of stroke with darbepoetin alfa in anaemic heart failure patients with diabetes and chronic kidney disease

    Article • European Journal of Heart Failure, October 2015, Wiley

    Professor john j mcmurray

  134. Is heart rate a risk marker in patients with chronic heart failure and concomitant atrial fibrillation? Results from the MAGGIC meta-analysis

    Article • European Journal of Heart Failure, September 2015, Wiley

    Professor john j mcmurray

  135. Cardiovascular safety of albiglutide in the Harmony programme: a meta-analysis

    Article • The Lancet Diabetes & Endocrinology, September 2015, Elsevier

    Professor john j mcmurray

  136. Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)

    Article • American Journal of Kidney Diseases, September 2015, Elsevier

    Professor john j mcmurray

  137. Acute Heart Failure and Atrial Fibrillation: Insights From the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND‐HF) Trial

    Article • Journal of the American Heart Association, August 2015, Wolters Kluwer Health

    Professor john j mcmurray

  138. Secreted Frizzled Related Protein 3 in Chronic Heart Failure: Analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)

    Article • PLoS ONE, August 2015, PLOS

    Professor john j mcmurray, Professor John GF Cleland

  139. Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response

    Article • European Journal of Heart Failure, August 2015, Wiley

    Professor john j mcmurray

  140. Predictors of clinical outcomes in acute decompensated heart failure: Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure outcome models

    Article • American Heart Journal, August 2015, Elsevier

    Professor john j mcmurray

  141. Race and ethnicity influences on cardiovascular and renal events in patients with diabetes mellitus

    Article • American Heart Journal, August 2015, Elsevier

    Professor john j mcmurray

  142. Combined Free Light Chains Are Novel Predictors of Prognosis in Heart Failure

    Article • JACC Heart Failure, August 2015, Elsevier

    Professor john j mcmurray

  143. Falling Cardiovascular Mortality in Heart Failure With Reduced Ejection Fraction and Implications for Clinical Trials

    Article • JACC Heart Failure, August 2015, Elsevier

    Professor john j mcmurray

  144. Prospective relationships between body weight and physical activity: an observational analysis from the NAVIGATOR study

    Article • BMJ Open, August 2015, BMJ

    Professor john j mcmurray

  145. Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HF

    Article • European Heart Journal, July 2015, European Society of Cardiology

    Professor john j mcmurray, Professor Vladimir V Rafalskiy

  146. Assessment and prevalence of pulmonary oedema in contemporary acute heart failure trials: a systematic review

    Article • European Journal of Heart Failure, July 2015, Wiley

    Professor john j mcmurray

  147. Mortality following a cardiovascular or renal event in patients with type 2 diabetes in the ALTITUDE trial

    Article • European Heart Journal, July 2015, European Society of Cardiology

    Professor john j mcmurray, Larry Weinrauch

  148. Clinical outcomes according to QRS duration and morphology in the Eplerenone in Mild Patients: Hospitalization and SurvIval Study in Heart Failure (EMPHASIS-HF)

    Article • European Journal of Heart Failure, July 2015, Wiley

    Professor john j mcmurray

  149. Meta-Analysis of Large-Scale Randomized Trials to Determine the Effectiveness of Inhibition of the Renin-Angiotensin Aldosterone System in Heart Failure

    Article • The American Journal of Cardiology, July 2015, Elsevier

    Professor john j mcmurray

  150. Clinical benefits of eplerenone in patients with systolic heart failure and mild symptoms when initiated shortly after hospital discharge: analysis from the EMPHASIS-HF trial

    Article • European Heart Journal, June 2015, European Society of Cardiology

    Professor Faiez zannad, Professor john j mcmurray

  151. Clinical Characteristics and Outcomes of Patients With Coronary Artery Disease and AnginaCLINICAL PERSPECTIVE

    Article • Circulation Heart Failure, June 2015, Wolters Kluwer Health

    Professor john j mcmurray

  152. Ethnic-Specific Normative Reference Values for Echocardiographic LA and LV Size, LV Mass, and Systolic Function

    Article • JACC Cardiovascular Imaging, June 2015, Elsevier

    Professor Luigi P. Badano, Professor john j mcmurray, Jose Krieger, Professor Thierry C Gillebert

  153. The Emerging Potential of the Apelin-APJ System in Heart Failure

    Article • Journal of Cardiac Failure, June 2015, Elsevier

    Professor john j mcmurray

  154. Relative Importance of History of Heart Failure Hospitalization and N-Terminal Pro–B-Type Natriuretic Peptide Level as Predictors of Outcomes in Patients With Heart Failure and Preserved Ejection Fraction

    Article • JACC Heart Failure, June 2015, Elsevier

    Professor john j mcmurray, Professor John GF Cleland

  155. The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction

    Article • JACC Heart Failure, June 2015, Elsevier

    Professor john j mcmurray

  156. Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients

    Article • European Heart Journal, May 2015, European Society of Cardiology

    Professor john j mcmurray

  157. Recommendations on pre-hospital and early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Eme...

    Article • European Heart Journal, May 2015, European Society of Cardiology

    Professor john j mcmurray

  158. Recommendations on pre-hospital & early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergenc

    Article • European Journal of Heart Failure, May 2015, Wiley

    Professor john j mcmurray

  159. It is BEAUTIFUL we should be concerned about, not SIGNIFY: is ivabradine less effective in ischaemic compared with non-ischaemic LVSD?

    Article • European Heart Journal, May 2015, European Society of Cardiology

    Professor john j mcmurray

  160. Prognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction: results from the MAGGIC individual patient data meta-analysis

    Article • QJM, May 2015, Oxford University Press (OUP)

    Professor john j mcmurray

  161. Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo

    Article • American Heart Journal, May 2015, Elsevier

    Professor Vladimir V Rafalskiy, Professor john j mcmurray, Professor Tzung-Dau Wang, Professor Rayaz Ahmed Malik

  162. Changes in N-terminal pro-B-type natriuretic peptide levels and outcomes in heart failure with preserved ejection fraction: an analysis of the I-Preserve study

    Article • European Journal of Heart Failure, April 2015, Wiley

    Professor john j mcmurray

  163. Physical activity as a determinant of fasting and 2-h post-challenge glucose: a prospective cohort analysis of the NAVIGATOR trial

    Article • Diabetic Medicine, April 2015, Wiley

    Professor john j mcmurray

  164. Pulse pressure is not an independent predictor of outcome in type 2 diabetes patients with chronic kidney disease and anemia—the Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT)

    Article • Journal of Human Hypertension, March 2015, Nature

    Professor john j mcmurray

  165. Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-He...

    Article • Circulation, March 2015, Wolters Kluwer Health

    Professor john j mcmurray, Gian Luigi Nicolosi

  166. The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials

    Article • European Heart Journal, March 2015, European Society of Cardiology

    Professor john j mcmurray

  167. The diagnostic accuracy of the natriuretic peptides in heart failure: systematic review and diagnostic meta-analysis in the acute care setting

    Article • BMJ, March 2015, BMJ

    Professor john j mcmurray

  168. Neprilysin inhibition to treat heart failure: a tale of science, serendipity, and second chances

    Article • European Journal of Heart Failure, March 2015, Wiley

    Professor john j mcmurray

  169. Acute Heart Failure in the Elderly: Differences in Clinical Characteristics, Outcomes, and Prognostic Factors in the VERITAS Study

    Article • Journal of Cardiac Failure, March 2015, Elsevier

    Professor john j mcmurray, Professor John GF Cleland

  170. Venous Thromboembolism and Cardiovascular Risk: Results from the NAVIGATOR Trial

    Article • The American Journal of Medicine, March 2015, Elsevier

    Professor john j mcmurray

  171. Do statins reduce the risk of myocardial infarction in patients with heart failure? A pooled individual-level reanalysis of CORONA and GISSI-HF

    Article • European Journal of Heart Failure, February 2015, Wiley

    Professor john j mcmurray

  172. Sex differences in clinical characteristics and outcomes after myocardial infarction: insights from the Valsartan in Acute Myocardial Infarction Trial (VALIANT)

    Article • European Journal of Heart Failure, February 2015, Wiley

    Professor john j mcmurray

  173. Renal effects of the angiotensin receptor neprilysin inhibitor LCZ696 in patients with heart failure and preserved ejection fraction

    Article • European Journal of Heart Failure, February 2015, Wiley

    Professor john j mcmurray

  174. Site selection for heart failure clinical trials in the USA

    Article • Heart Failure Reviews, February 2015, Springer Science + Business Media

    Professor Giuseppe M C Rosano, Professor john j mcmurray

  175. Telomere length and outcomes in ischaemic heart failure: data from the COntrolled ROsuvastatin multiNAtional Trial in Heart Failure (CORONA)

    Article • European Journal of Heart Failure, February 2015, Wiley

    Professor john j mcmurray

  176. Clinical characteristics and outcomes of patients with angina and heart failure in the CHARM (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity) Programme

    Article • European Journal of Heart Failure, February 2015, Wiley

    Professor john j mcmurray

  177. Novel Extracellular Matrix Biomarkers as Predictors of Adverse Outcome in Chronic Heart Failure: Association Between Biglycan and Response to Statin Therapy in the CORONA Trial

    Article • Journal of Cardiac Failure, February 2015, Elsevier

    Professor john j mcmurray

  178. Differing prognostic value of pulse pressure in patients with heart failure with reduced or preserved ejection fraction: results from the MAGGIC individual patient meta-analysis

    Article • European Heart Journal, January 2015, European Society of Cardiology

    Professor john j mcmurray

  179. Loop diuretic dose adjustments after a hospitalization for heart failure: insights from ASCEND-HF

    Article • European Journal of Heart Failure, January 2015, Wiley

    Professor john j mcmurray

  180. Temporal trends and risk factors for readmission for infections, gastrointestinal and immobility complications after an incident hospitalisation for stroke in Scotland between 1997 and 2005

    Article • BMC Neurology, January 2015, Springer Science + Business Media

    Professor john j mcmurray

  181. HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials

    Article • The Lancet, January 2015, Elsevier

    Dr Paul C D Johnson, Dr Michael V Holmes, Professor john j mcmurray

  182. Predictive Value of Endostatin in Chronic Heart Failure Patients with Poor Kidney Function

    Article • Cardiology, January 2015, Karger Publishers

    Professor john j mcmurray

  183. Comparative Assessment of Short-Term Adverse Events in Acute Heart Failure With Cystatin C and Other Estimates of Renal Function

    Article • JACC Heart Failure, January 2015, Elsevier

    Professor john j mcmurray

  184. ‘Hearts and minds’: association, causation and implication of cognitive impairment in heart failure

    Article • Alzheimer s Research & Therapy, January 2015, Springer Science + Business Media

    Professor john j mcmurray

  185. Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fraction

    Article • European Journal of Heart Failure, December 2014, Wiley

    Professor john j mcmurray, Professor John GF Cleland

  186. Neprilysin Inhibition for Heart Failure

    Article • New England Journal of Medicine, December 2014, New England Journal of Medicine (NEJM/MMS)

    Professor john j mcmurray

  187. β blockers, atrial fibrillation, and heart failure

    Article • The Lancet, December 2014, Elsevier

    Professor john j mcmurray

  188. Comparison of Cardiac Troponins I and T Measured with High-Sensitivity Methods for Evaluation of Prognosis in Atrial Fibrillation: An ARISTOTLE Substudy

    Article • Clinical Chemistry, December 2014, AACC

    Professor john j mcmurray

  189. Acute decompensated heart failure patients admitted to critical care units: Insights from ASCEND-HF

    Article • International Journal of Cardiology, December 2014, Elsevier

    Professor john j mcmurray

  190. Risk Factors for Heart Failure in Patients With Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated With Bardoxolone Methyl

    Article • Journal of Cardiac Failure, December 2014, Elsevier

    Professor john j mcmurray

  191. The association between meteorological events and acute heart failure: New insights from ASCEND-HF

    Article • International Journal of Cardiology, December 2014, Elsevier

    Professor john j mcmurray

  192. Acute heart failure: have we got it all wrong?

    Article • European Journal of Heart Failure, November 2014, Wiley

    Professor john j mcmurray

  193. A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failure

    Article • European Heart Journal, November 2014, European Society of Cardiology

    Professor john j mcmurray, Professor Vladimir V Rafalskiy

  194. International Geographic Variation in Event Rates in Trials of Heart Failure With Preserved and Reduced Ejection Fraction

    Article • Circulation, November 2014, Wolters Kluwer Health

    Professor john j mcmurray

  195. Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure

    Article • Circulation, November 2014, Wolters Kluwer Health

    Professor Vladimir V Rafalskiy, Professor john j mcmurray, Professor Thomas Munzel or Muenzel

  196. Worsening heart failure, a critical event during hospital admission for acute heart failure: results from the VERITAS study

    Article • European Journal of Heart Failure, November 2014, Wiley

    Professor john j mcmurray, Professor John GF Cleland

  197. Prognostic importance of temporal changes in resting heart rate in heart failure patients: an analysis of the CHARM program

    Article • European Heart Journal, November 2014, European Society of Cardiology

    Professor john j mcmurray

  198. Treatment of severe hypertriglyceridaemia

    Article • The Lancet Diabetes & Endocrinology, November 2014, Elsevier

    Professor john j mcmurray

  199. Gut Feelings About Heart Failure∗

    Article • Journal of the American College of Cardiology, November 2014, Elsevier

    Professor john j mcmurray

  200. Influence of Hospitalization for Cardiovascular Versus Noncardiovascular Reasons on Subsequent Mortality in Patients With Chronic Heart Failure Across the Spectrum of Ejection Fraction

    Article • Circulation Heart Failure, October 2014, Wolters Kluwer Health

    Professor john j mcmurray

  201. A prediction model for sudden cardiac death in patients with heart failure and preserved ejection fraction

    Article • European Journal of Heart Failure, October 2014, Wiley

    Professor john j mcmurray

  202. Diagnosing and managing acute heart failure in adults: summary of NICE guidance

    Article • BMJ, October 2014, BMJ

    Professor john j mcmurray

  203. Hypotension During Hospitalization for Acute Heart Failure Is Independently Associated With 30-Day Mortality: Findings From ASCEND-HF

    Article • Circulation Heart Failure, October 2014, Wolters Kluwer Health

    Professor john j mcmurray

  204. Elevation in High-Sensitivity Troponin T in Heart Failure and Preserved Ejection Fraction and Influence of Treatment With the Angiotensin Receptor Neprilysin Inhibitor LCZ696

    Article • Circulation Heart Failure, October 2014, Wolters Kluwer Health

    Professor john j mcmurray

  205. Chronic obstructive pulmonary disease and cardiovascular risk: Insights from the NAVIGATOR trial

    Article • International Journal of Cardiology, October 2014, Elsevier

    Professor john j mcmurray

  206. Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored

    Article • The Lancet Diabetes & Endocrinology, October 2014, Elsevier

    Professor john j mcmurray

  207. Reply

    Article • Journal of the American College of Cardiology, October 2014, Elsevier

    Professor john j mcmurray

  208. Risk Prediction in Patients With Heart Failure

    Article • JACC Heart Failure, October 2014, Elsevier

    Professor john j mcmurray

  209. Relationship between angina pectoris and outcomes in patients with heart failure and reduced ejection fraction: an analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)

    Article • European Heart Journal, September 2014, European Society of Cardiology

    Professor john j mcmurray, Professor John GF Cleland

  210. History of Atrial Fibrillation as a Risk Factor in Patients With Heart Failure and Preserved Ejection Fraction

    Article • Circulation Heart Failure, September 2014, Wolters Kluwer Health

    Professor john j mcmurray

  211. Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

    Article • New England Journal of Medicine, September 2014, New England Journal of Medicine (NEJM/MMS)

    Professor Vladimir V Rafalskiy, Professor john j mcmurray, Professor Thomas Munzel or Muenzel

  212. PARADIGM-HF — The Experts' Discussion

    Article • New England Journal of Medicine, September 2014, New England Journal of Medicine (NEJM/MMS)

    Professor john j mcmurray

  213. Worsening Renal Function and Outcome in Heart Failure Patients With Preserved Ejection Fraction and the Impact of Angiotensin Receptor Blocker Treatment

    Article • Journal of the American College of Cardiology, September 2014, Elsevier

    Professor john j mcmurray

  214. Associations of chronic heart failure with outcome in acute ischaemic stroke patients who received systemic thrombolysis: analysis from VISTA

    Article • European Journal of Neurology, August 2014, Wiley

    Professor john j mcmurray

  215. Terminology and definition of changes renal function in heart failure

    Article • European Heart Journal, August 2014, European Society of Cardiology

    Professor john j mcmurray

  216. Impaired left atrial function in heart failure with preserved ejection fraction

    Article • European Journal of Heart Failure, August 2014, Wiley

    Professor john j mcmurray

  217. Heart Failure Care in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis

    Article • PLoS Medicine, August 2014, PLOS

    Professor john j mcmurray

  218. Up-titration of allopurinol in patients with gout

    Article • Seminars in Arthritis and Rheumatism, August 2014, Elsevier

    Professor john j mcmurray

  219. Nesiritide, Renal Function, and Associated Outcomes During Hospitalization for Acute Decompensated Heart Failure: Results From the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF)

    Article • Circulation, July 2014, Wolters Kluwer Health

    Professor john j mcmurray

  220. Protocol of the Febuxostat versus Allopurinol Streamlined Trial (FAST): a large prospective, randomised, open, blinded endpoint study comparing the cardiovascular safety of allopurinol and febuxostat in the management of symptomatic hyperuricaemia

    Article • BMJ Open, July 2014, BMJ

    Professor john j mcmurray

  221. Cost-effectiveness of eplerenone in patients with systolic heart failure and mild symptoms

    Article • Heart, July 2014, BMJ

    Professor john j mcmurray

  222. Rationale for and design of the Acarbose Cardiovascular Evaluation (ACE) trial

    Article • American Heart Journal, July 2014, Elsevier

    Professor john j mcmurray

  223. Comorbidities and Differential Diagnosis in Heart Failure with Preserved Ejection Fraction

    Article • Heart Failure Clinics, July 2014, Elsevier

    Professor john j mcmurray

  224. Correction

    Article • Journal of the American College of Cardiology, July 2014, Elsevier

    Professor john j mcmurray

  225. Association between renal function and cardiovascular structure and function in heart failure with preserved ejection fraction

    Article • European Heart Journal, June 2014, European Society of Cardiology

    Professor john j mcmurray

  226. Change in levels of physical activity after diagnosis of type 2 diabetes: an observational analysis from the NAVIGATOR study

    Article • Diabetes Obesity and Metabolism, June 2014, Wiley

    Professor john j mcmurray

  227. Heart failure in younger patients: the Meta-analysis Global Group in Chronic Heart Failure (MAGGIC)

    Article • European Heart Journal, June 2014, European Society of Cardiology

    Dr Chih Mun Wong, Professor john j mcmurray

  228. Baseline characteristics and treatment of patients in Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF)

    Article • European Journal of Heart Failure, June 2014, Wiley

    Professor john j mcmurray, Professor Vladimir V Rafalskiy

  229. Effect of Rosuvastatin on Repeat Heart Failure Hospitalizations

    Article • JACC Heart Failure, June 2014, Elsevier

    Professor john j mcmurray, Professor John GF Cleland

  230. Influence of Previous Heart Failure Hospitalization on Cardiovascular Events in Patients With Reduced and Preserved Ejection FractionCLINICAL PERSPECTIVE

    Article • Circulation Heart Failure, May 2014, Wolters Kluwer Health

    Professor john j mcmurray

  231. Relationship between heart rate and mortality and morbidity in the irbesartan patients with heart failure and preserved systolic function trial (I-Preserve)

    Article • European Journal of Heart Failure, May 2014, Wiley

    Michael Böhm, Professor john j mcmurray

  232. High-Sensitivity C-Reactive Protein in Acute Heart Failure: Insights From the ASCEND-HF Trial

    Article • Journal of Cardiac Failure, May 2014, Elsevier

    Professor john j mcmurray

  233. Digitalis for treatment of heart failure in patients in sinus rhythm

    Article • Cochrane Database of Systematic Reviews, April 2014, Wiley

    Professor john j mcmurray

  234. Corrigendum to ‘Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved’ [Eur J Heart Fail2014;16:33-40]

    Article • European Journal of Heart Failure, April 2014, Wiley

    Professor john j mcmurray

  235. Lessons from the TOPCAT Trial

    Article • New England Journal of Medicine, April 2014, New England Journal of Medicine (NEJM/MMS)

    Professor john j mcmurray

  236. Independence of the blood pressure lowering effect and efficacy of the angiotensin receptor neprilysin inhibitor, LCZ696, in patients with heart failure with preserved ejection fraction: an analysis of the PARAMOUNT trial

    Article • European Journal of Heart Failure, April 2014, Wiley

    Professor john j mcmurray

  237. Developing Therapies for Heart Failure With Preserved Ejection Fraction

    Article • JACC Heart Failure, April 2014, Elsevier

    Professor Giuseppe M C Rosano, Professor john j mcmurray, Professor John GF Cleland

  238. Fatigue as a Predictor of Outcome in Patients With Heart Failure

    Article • JACC Heart Failure, April 2014, Elsevier

    Professor john j mcmurray, Professor John GF Cleland

  239. Impact of baseline physical activity and diet behavior on metabolic syndrome in a pharmaceutical trial: Results from NAVIGATOR

    Article • Metabolism, April 2014, Elsevier

    Professor john j mcmurray

  240. Retinopathy and clinical outcomes in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia

    Article • BMJ Open Diabetes Research & Care, April 2014, BMJ

    Professor john j mcmurray, Larry Weinrauch

  241. EURObservational Research Programme: a worldwide registry on peripartum cardiomyopathy (PPCM) in conjunction with the Heart Failure Association of the European Society of Cardiology Working Group on PPCM

    Article • European Journal of Heart Failure, March 2014, Wiley

    Professor john j mcmurray

  242. Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis

    Article • The Lancet, March 2014, Elsevier

    Professor john j mcmurray

  243. Current Evidence on Treatment of Patients With Chronic Systolic Heart Failure and Renal Insufficiency

    Article • Journal of the American College of Cardiology, March 2014, Elsevier

    Professor john j mcmurray

  244. Sex‐specific cardiovascular structure and function in heart failure with preserved ejection fraction

    Article • European Journal of Heart Failure, February 2014, Wiley

    Professor john j mcmurray

  245. Thyroid-Stimulating Hormone and Clinical Outcomes

    Article • JACC Heart Failure, February 2014, Elsevier

    Professor john j mcmurray, Professor John GF Cleland

  246. Impaired Systolic Function by Strain Imaging in Heart Failure With Preserved Ejection Fraction

    Article • Journal of the American College of Cardiology, February 2014, Elsevier

    Professor john j mcmurray

  247. Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial

    Article • The Lancet Diabetes & Endocrinology, February 2014, Elsevier

    Professor john j mcmurray

  248. Effects of Neutral Endopeptidase (Neprilysin) Inhibition on the Response to Other Vasoactive Peptides in Small Human Resistance Arteries: Studies with Thiorphan and Omapatrilat

    Article • Cardiovascular Therapeutics, January 2014, Wiley

    Professor john j mcmurray

  249. Response to Letter Regarding Article, “Efficacy and Safety of Apixaban Compared With Warfarin at Different Levels of Predicted International Normalized Ratio Control for Stroke Prevention in Atrial Fibrillation”

    Article • Circulation, January 2014, Wolters Kluwer Health

    Professor john j mcmurray

  250. Large streamlined trials in cardiovascular disease

    Article • European Heart Journal, January 2014, European Society of Cardiology

    Professor john j mcmurray

  251. High-Sensitivity Troponin T and Risk Stratification in Patients With Atrial Fibrillation During Treatment With Apixaban or Warfarin

    Article • Journal of the American College of Cardiology, January 2014, Elsevier

    Professor john j mcmurray

  252. Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease

    Article • New England Journal of Medicine, December 2013, New England Journal of Medicine (NEJM/MMS)

    Professor john j mcmurray

  253. Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved

    Article • European Journal of Heart Failure, December 2013, Wiley

    Professor john j mcmurray

  254. Microvolt T-wave alternans testing in patients recently hospitalized with decompensated heart failure

    Article • European Journal of Heart Failure, December 2013, Wiley

    Professor john j mcmurray

  255. Role of diuretics,   blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study

    Article • BMJ, December 2013, BMJ

    Professor john j mcmurray

  256. The impact of kidney function on outcomes following high risk myocardial infarction: findings from 27 610 patients

    Article • European Journal of Heart Failure, December 2013, Wiley

    Professor john j mcmurray

  257. Why and when should we worry about worsening renal function?

    Article • European Journal of Heart Failure, December 2013, Wiley

    Professor john j mcmurray

  258. Inflammatory cytokines in chronic heart failure: interleukin-8 is associated with adverse outcome. Results from CORONA

    Article • European Journal of Heart Failure, December 2013, Wiley

    Professor john j mcmurray

  259. Incidence, Determinants, and Prognostic Significance of Hyperkalemia and Worsening Renal Function in Patients With Heart Failure Receiving the Mineralocorticoid Receptor Antagonist Eplerenone or Placebo in Addition to Optimal Medical Therapy: Results F...

    Article • Circulation Heart Failure, December 2013, Wolters Kluwer Health

    Professor john j mcmurray

  260. Prognostic Effect of High-Sensitive Troponin T Assessment in Elderly Patients With Chronic Heart Failure: Results From the CORONA Trial

    Article • Circulation Heart Failure, November 2013, Wolters Kluwer Health

    Professor john j mcmurray

  261. A meta-analysis of echocardiographic measurements of the left heart for the development of normative reference ranges in a large international cohort: the EchoNoRMAL study

    Article • European Heart Journal - Cardiovascular Imaging, November 2013, European Society of Cardiology

    Professor Luigi P. Badano, Professor john j mcmurray, Professor Thierry C Gillebert

  262. High-Sensitivity Troponin I for Risk Assessment in Patients With Atrial Fibrillation: Insights From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial

    Article • Circulation, November 2013, Wolters Kluwer Health

    Professor john j mcmurray

  263. Incidence of atrial fibrillation in a population with impaired glucose tolerance: The contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial

    Article • American Heart Journal, November 2013, Elsevier

    Professor john j mcmurray

  264. Clinical Characteristics and Outcomes of Young and Very Young Adults With Heart Failure

    Article • Journal of the American College of Cardiology, November 2013, Elsevier

    Dr Chih Mun Wong, Professor john j mcmurray

  265. Known and missing left ventricular ejection fraction and survival in patients with heart failure: a MAGGIC meta-analysis report

    Article • European Journal of Heart Failure, November 2013, Wiley

    Professor john j mcmurray

  266. Losing ALTITUDE? How should ASTRONAUT launch into ATMOSPHERE

    Article • European Journal of Heart Failure, November 2013, Wiley

    Professor john j mcmurray

  267. Spectral microvolt T-wave alternans testing has no prognostic value in patients recently hospitalized with decompensated heart failure

    Article • European Journal of Heart Failure, November 2013, Wiley

    Professor john j mcmurray

  268. The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data

    Article • International Journal of Obesity, October 2013, Nature

    Professor john j mcmurray

  269. Baseline characteristics in the Bardoxolone methyl EvAluation in patients with Chronic kidney disease and type 2 diabetes mellitus: the Occurrence of renal eveNts (BEACON) trial

    Article • Nephrology Dialysis Transplantation, October 2013, Oxford University Press (OUP)

    Professor john j mcmurray

  270. Left ventricular dyssynchrony in patients with heart failure and preserved ejection fraction

    Article • European Heart Journal, October 2013, European Society of Cardiology

    Professor john j mcmurray

  271. The large-scale placebo-controlled beta-blocker studies in systolic heart failure revisited: results from CIBIS-II, COPERNICUS and SENIORS-SHF compared with stratified subsets from MERIT-HF

    Article • Journal of Internal Medicine, October 2013, Wiley

    Professor john j mcmurray

  272. Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial

    Article • European Heart Journal, October 2013, European Society of Cardiology

    Professor john j mcmurray

  273. ECG — Still the Best for Selecting Patients for CRT

    Article • New England Journal of Medicine, October 2013, New England Journal of Medicine (NEJM/MMS)

    Professor john j mcmurray

  274. Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document

    Article • European Journal of Heart Failure, October 2013, Wiley

    Professor Giuseppe M C Rosano, Professor john j mcmurray, Professor John GF Cleland

  275. Prognostic value of CXCL16 in patients with left ventricular systolic dysfunction and heart failure

    Article • International Journal of Cardiology, October 2013, Elsevier

    Professor john j mcmurray, Professor John GF Cleland

  276. 2013 ACCF/AHA Guideline for the Management of Heart Failure

    Article • Journal of the American College of Cardiology, October 2013, Elsevier

    Professor john j mcmurray

  277. Safety and Efficacy of Eplerenone in Patients at High Risk for Hyperkalemia and/or Worsening Renal Function

    Article • Journal of the American College of Cardiology, October 2013, Elsevier

    Professor john j mcmurray

  278. 2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary

    Article • Journal of the American College of Cardiology, October 2013, Elsevier

    Professor john j mcmurray

  279. The past, present and future of renin–angiotensin aldosterone system inhibition

    Article • International Journal of Cardiology, September 2013, Elsevier

    Dr Robert John Mentz, Professor john j mcmurray

  280. Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact

    Article • European Journal of Heart Failure, September 2013, Wiley

    Professor Vladimir V Rafalskiy, Professor john j mcmurray

  281. Organization of heart failure management in European Society of Cardiology member countries: survey of the Heart Failure Association of the European Society of Cardiology in collaboration with the Heart Failure National Societies/Working Groups

    Article • European Journal of Heart Failure, September 2013, Wiley

    Professor john j mcmurray

  282. Angina and intermittent claudication in 7403 participants of the 2003 Scottish Health Survey: Impact on general and mental health, quality of life and five-year mortality

    Article • International Journal of Cardiology, September 2013, Elsevier

    Professor john j mcmurray

  283. Atrial fibrillation: Profile and burden of an evolving epidemic in the 21st century

    Article • International Journal of Cardiology, September 2013, Elsevier

    Professor john j mcmurray

  284. Peripheral artery disease and outcomes after myocardial infarction: An individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANT

    Article • International Journal of Cardiology, September 2013, Elsevier

    Professor john j mcmurray

  285. Cardiovascular Risks with Azithromycin

    Article • New England Journal of Medicine, August 2013, New England Journal of Medicine (NEJM/MMS)

    Professor john j mcmurray

  286. Methodology of a reevaluation of cardiovascular outcomes in the RECORD trial: Study design and conduct

    Article • American Heart Journal, August 2013, Elsevier

    Professor john j mcmurray

  287. Results of a reevaluation of cardiovascular outcomes in the RECORD trial

    Article • American Heart Journal, August 2013, Elsevier

    Professor john j mcmurray

  288. Darbepoetin Alfa in Systolic Heart Failure

    Article • New England Journal of Medicine, August 2013, New England Journal of Medicine (NEJM/MMS)

    Professor john j mcmurray

  289. Digoxin Reduces 30-day All-cause Hospital Admission in Older Patients with Chronic Systolic Heart Failure

    Article • The American Journal of Medicine, August 2013, Elsevier

    Professor john j mcmurray, Dr. Richard M Allman, Professor John GF Cleland

  290. Predictors of Stroke in Patients With Impaired Glucose Tolerance

    Article • Stroke, July 2013, Wolters Kluwer Health

    Professor john j mcmurray

  291. The impact of eplerenone at different levels of risk in patients with systolic heart failure and mild symptoms: insight from a novel risk score for prognosis derived from the EMPHASIS-HF trial

    Article • European Heart Journal, July 2013, European Society of Cardiology

    Professor john j mcmurray

  292. A Novel Risk Classification Paradigm for Patients With Impaired Glucose Tolerance and High Cardiovascular Risk

    Article • The American Journal of Cardiology, July 2013, Elsevier

    Professor john j mcmurray

  293. CCL21 is associated with fatal outcomes in chronic heart failure: data from CORONA and GISSI-HF trials

    Article • European Journal of Heart Failure, July 2013, Wiley

    Professor john j mcmurray

  294. Response to Letter Regarding Article, "Galectin-3 and Cardiac Function in Survivors of Acute Myocardial Infarction"

    Article • Circulation Heart Failure, July 2013, Wolters Kluwer Health

    Professor john j mcmurray

  295. Do Countries or Hospitals With Longer Hospital Stays for Acute Heart Failure Have Lower Readmission Rates?: Findings From ASCEND-HF

    Article • Circulation Heart Failure, June 2013, Wolters Kluwer Health

    Professor john j mcmurray

  296. 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

    Article • Circulation, June 2013, Wolters Kluwer Health

    Professor john j mcmurray

  297. 2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

    Article • Circulation, June 2013, Wolters Kluwer Health

    Professor john j mcmurray

  298. N-Terminal Pro–B-Type Natriuretic Peptide for Risk Assessment in Patients With Atrial Fibrillation

    Article • Journal of the American College of Cardiology, June 2013, Elsevier

    Professor john j mcmurray

  299. Efficacy and Safety of Apixaban Compared With Warfarin at Different Levels of Predicted International Normalized Ratio Control for Stroke Prevention in Atrial Fibrillation

    Article • Circulation, May 2013, Wolters Kluwer Health

    Professor john j mcmurray

  300. Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial

    Article • European Journal of Heart Failure, May 2013, Wiley

    Professor john j mcmurray, Professor John GF Cleland

  301. Clinical Benefit of Eplerenone in Patients With Mild Symptoms of Systolic Heart Failure Already Receiving Optimal Best Practice Background Drug Therapy: Analysis of the EMPHASIS-HF Study

    Article • Circulation Heart Failure, April 2013, Wolters Kluwer Health

    Professor john j mcmurray

  302. Left Ventricular Systolic Dysfunction, Heart Failure, and the Risk of Stroke and Systemic Embolism in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial

    Article • Circulation Heart Failure, April 2013, Wolters Kluwer Health

    Professor john j mcmurray

  303. Reply

    Article • Journal of the American College of Cardiology, April 2013, Elsevier

    Professor john j mcmurray

  304. Effect of Levosimendan on the Short-Term Clinical Course of Patients With Acutely Decompensated Heart Failure

    Article • JACC Heart Failure, April 2013, Elsevier

    Professor john j mcmurray

  305. Treatment of Anemia with Darbepoetin Alfa in Systolic Heart Failure

    Article • New England Journal of Medicine, March 2013, New England Journal of Medicine (NEJM/MMS)

    Professor john j mcmurray

  306. Beta-blockers in cardiovascular medicine: still alive and kicking

    Article • Prescriber, March 2013, Wiley

    Professor john j mcmurray

  307. Aliskiren increased adverse events in patients with diabetes and kidney disease who were receiving ACE inhibitors or ARBs

    Article • Annals of Internal Medicine, March 2013, American College of Physicians

    Professor john j mcmurray

  308. Galectin-3 and Cardiac Function in Survivors of Acute Myocardial Infarction

    Article • Circulation Heart Failure, March 2013, Wolters Kluwer Health

    Professor john j mcmurray

  309. Aliskiren in Type 2 Diabetes and Cardiorenal End Points

    Article • New England Journal of Medicine, March 2013, New England Journal of Medicine (NEJM/MMS)

    Professor john j mcmurray

  310. Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF)

    Article • European Journal of Heart Failure, March 2013, Wiley

    Professor john j mcmurray

  311. Effect of Rosuvastatin on Fatigue in Patients With Heart Failure

    Article • Journal of the American College of Cardiology, March 2013, Elsevier

    Professor john j mcmurray

  312. Corrigendum to: ‘ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012’ [Eur J Heart Fail 2012;14: 803-869]

    Article • European Journal of Heart Failure, March 2013, Wiley

    Professor john j mcmurray

  313. Predictors of Incident Heart Failure Hospitalizations Among Patients With Impaired Glucose Tolerance: Insight From the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research Study

    Article • Circulation Heart Failure, February 2013, Wolters Kluwer Health

    Professor john j mcmurray

  314. Antithrombotic outcome trials in acute coronary syndromes: seeking the optimal balance between safety and efficacy†

    Article • European Heart Journal, February 2013, European Society of Cardiology

    Professor john j mcmurray

  315. Beta-Blockers and Outcome in Heart Failure and Atrial Fibrillation

    Article • JACC Heart Failure, February 2013, Elsevier

    Professor john j mcmurray

  316. Hemoglobin Stability in Patients With Anemia, CKD, and Type 2 Diabetes: An Analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) Placebo Arm

    Article • American Journal of Kidney Diseases, February 2013, Elsevier

    Professor john j mcmurray

  317. Letter by MacDonald et al Regarding Article, "Catheter Ablation of Atrial Fibrillation"

    Article • Circulation, January 2013, Wolters Kluwer Health

    Professor john j mcmurray

  318. Pharmacological treatment of heart failure with preserved ejection fraction: a glimpse of light at the end of the tunnel?

    Article • European Journal of Heart Failure, January 2013, Wiley

    Professor john j mcmurray

  319. Rationale and Trial Design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: The Occurrence of Renal Events (BEACON)

    Article • American Journal of Nephrology, January 2013, Karger Publishers

    Professor john j mcmurray

  320. Soluble Glycoprotein 130 Predicts Fatal Outcomes in Chronic Heart Failure: Analysis From the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)

    Article • Circulation Heart Failure, December 2012, Wolters Kluwer Health

    Professor john j mcmurray, Professor John GF Cleland

  321. Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes

    Article • New England Journal of Medicine, December 2012, New England Journal of Medicine (NEJM/MMS)

    Dr Frederik Persson, Professor john j mcmurray, Massimo Volpe

  322. The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)

    Article • American Heart Journal, December 2012, Elsevier

    Professor john j mcmurray

  323. What Have We Learned About Patients With Heart Failure and Preserved Ejection Fraction From DIG-PEF, CHARM-Preserved, and I-PRESERVE?

    Article • Journal of the American College of Cardiology, December 2012, Elsevier

    Professor john j mcmurray

  324. Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome

    Article • New England Journal of Medicine, November 2012, New England Journal of Medicine (NEJM/MMS)

    Professor john j mcmurray

  325. Corrigendum to: ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012’[Eur Heart J 2012;33:1787–1847, doi:10.1093/eurheartj/ehs104

    Article • European Heart Journal, November 2012, European Society of Cardiology

    Professor john j mcmurray

  326. Iron status in patients with chronic heart failure

    Article • European Heart Journal, November 2012, European Society of Cardiology

    Professor john j mcmurray

  327. Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial

    Article • The Lancet, November 2012, Elsevier

    Professor john j mcmurray

  328. How Small Is Too Small? A Systematic Review of Center Volume and Outcome After Cardiac Transplantation

    Article • Circulation Cardiovascular Quality and Outcomes, November 2012, Wolters Kluwer Health

    Professor john j mcmurray

  329. Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study

    Article • European Journal of Heart Failure, November 2012, Wiley

    Professor john j mcmurray

  330. Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies

    Article • European Heart Journal, October 2012, European Society of Cardiology

    Professor john j mcmurray

  331. Eplerenone in Patients With Systolic Heart Failure and Mild Symptoms: Analysis of Repeat Hospitalizations

    Article • Circulation, October 2012, Wolters Kluwer Health

    Professor john j mcmurray

  332. Lessons from the ESC Guidelines of the Management of Heart Failure (TBA)

    Article • Journal of Cardiac Failure, October 2012, Elsevier

    Professor john j mcmurray

  333. Prediabetes and the risk of diabetes

    Article • The Lancet, October 2012, Elsevier

    Professor john j mcmurray

  334. Guía de práctica clínica de la ESC sobre diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica 2012

    Article • Revista Española de Cardiología, October 2012, Elsevier

    Professor john j mcmurray

  335. Interleukin-21 – A biomarker of importance in predicting myocardial function following acute infarction?

    Article • Cytokine, October 2012, Elsevier

    Professor john j mcmurray

  336. The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial

    Article • The Lancet, October 2012, Elsevier

    Professor john j mcmurray

  337. The dual endothelin converting enzyme/neutral endopeptidase inhibitor SLV-306 (daglutril), inhibits systemic conversion of big endothelin-1 in humans

    Article • Life Sciences, October 2012, Elsevier

    Professor john j mcmurray, Dr Anthony P Davenport

  338. Effect of Statins on Venous Thromboembolic Events: A Meta-analysis of Published and Unpublished Evidence from Randomised Controlled Trials

    Article • PLoS Medicine, September 2012, PLOS

    Professor john j mcmurray

  339. 'European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)' The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted b...

    Article • European Heart Journal, September 2012, European Society of Cardiology

    Professor john j mcmurray

  340. Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice

    Article • European Heart Journal, August 2012, European Society of Cardiology

    Professor john j mcmurray

  341. Time to move on from 'time-to-first': should all events be included in the analysis of clinical trials?

    Article • European Heart Journal, August 2012, European Society of Cardiology

    Professor john j mcmurray

  342. Sex Differences in Clinical Characteristics and Outcomes in Elderly Patients With Heart Failure and Preserved Ejection Fraction: The Irbesartan in Heart Failure With Preserved Ejection Fraction (I-PRESERVE) Trial

    Article • Circulation Heart Failure, August 2012, Wolters Kluwer Health

    Professor john j mcmurray

  343. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

    Article • European Journal of Heart Failure, August 2012, Wiley

    Professor john j mcmurray

  344. Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF)

    Article • European Journal of Heart Failure, August 2012, Wiley

    Professor john j mcmurray

  345. Notice

    Article • Kidney International Supplements, August 2012, Elsevier

    Professor john j mcmurray

  346. Response to Letters Regarding Article, "Prevalence and Significance of Alterations in Cardiac Structure and Function in Patients With Heart Failure and a Preserved Ejection Fraction"

    Article • Circulation, July 2012, Wolters Kluwer Health

    Professor john j mcmurray

  347. Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Hypertension on Clinical End Points: A Cohort Study

    Article • Journal of Clinical Hypertension, July 2012, Wiley

    Professor john j mcmurray

  348. Thrombo-embolism and antithrombotic therapy for heart failure in sinus rhythm. A Joint Consensus Document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis

    Article • European Journal of Heart Failure, July 2012, Wiley

    Professor john j mcmurray

  349. Feasibility/eligibility of T-wave alternans testing in patients with heart failure: should we rethink our current modus operandi?: reply

    Article • European Journal of Heart Failure, June 2012, Wiley

    Professor john j mcmurray

  350. Microvolt T-wave alternans testing should be used to guide arrhythmic therapy in heart failure patients: reply

    Article • European Journal of Heart Failure, June 2012, Wiley

    Professor john j mcmurray

  351. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the He...

    Article • European Heart Journal, May 2012, European Society of Cardiology

    Professor john j mcmurray

  352. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by...

    Article • European Heart Journal, May 2012, European Society of Cardiology

    Professor john j mcmurray

  353. Reply to the letter by Dr Erqou regarding “Intensive glycemic control has no impact on the risk of heart failure in type 2 diabetic patients”

    Article • American Heart Journal, May 2012, Elsevier

    Prof. Giuseppe Biondi-Zoccai, Professor john j mcmurray

  354. Gender and survival in patients with heart failure: interactions with diabetes and aetiology. Results from the MAGGIC individual patient meta-analysis†

    Article • European Journal of Heart Failure, May 2012, Wiley

    Professor john j mcmurray

  355. Association of Heart Rate and Outcomes in a Broad Spectrum of Patients With Chronic Heart Failure

    Article • Journal of the American College of Cardiology, May 2012, Elsevier

    Professor john j mcmurray

  356. Eplerenone and Atrial Fibrillation in Mild Systolic Heart Failure

    Article • Journal of the American College of Cardiology, May 2012, Elsevier

    Professor john j mcmurray

  357. Mechanisms and Predictors of Mitral Regurgitation after High-Risk Myocardial Infarction

    Article • Journal of the American Society of Echocardiography, May 2012, Elsevier

    Professor john j mcmurray

  358. Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)

    Article • European Heart Journal, April 2012, European Society of Cardiology

    Professor john j mcmurray, Professor John GF Cleland

  359. Aliskiren, ALTITUDE, and the implications for ATMOSPHERE

    Article • European Journal of Heart Failure, April 2012, Wiley

    Professor john j mcmurray

  360. Assessment of Dyspnea in Acute Decompensated Heart Failure

    Article • Journal of the American College of Cardiology, April 2012, Elsevier

    Professor john j mcmurray

  361. Profile of microvolt T-wave alternans testing in 1003 patients hospitalized with heart failure

    Article • European Journal of Heart Failure, April 2012, Wiley

    Professor john j mcmurray

  362. Diabetes clinical trials: helped or hindered by the current shift in regulatory requirements?

    Article • European Heart Journal, March 2012, European Society of Cardiology

    Professor john j mcmurray, Professor John GF Cleland

  363. Should we SHIFT our thinking about digoxin? Observations on ivabradine and heart rate reduction in heart failure

    Article • European Heart Journal, March 2012, European Society of Cardiology

    Professor john j mcmurray

  364. B-type natriuretic peptide and glycaemia: an emerging cardiometabolic pathway?

    Article • Diabetologia, March 2012, Springer Science + Business Media

    Professor john j mcmurray

  365. Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiology

    Article • European Journal of Heart Failure, March 2012, Wiley

    Professor john j mcmurray, Professor John GF Cleland

  366. When to Stop a Clinical Trial Early for Benefit: Lessons Learned and Future Approaches

    Article • Circulation Heart Failure, March 2012, Wolters Kluwer Health

    Professor john j mcmurray

  367. Baseline characteristics in the Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE)

    Article • Journal of the Renin-Angiotensin-Aldosterone System, February 2012, SAGE Publications

    Dr Frederik Persson, Professor john j mcmurray

  368. Heart failure and socioeconomic status: accumulating evidence of inequality

    Article • European Journal of Heart Failure, February 2012, Wiley

    Professor john j mcmurray

  369. Left ventricular systolic and diastolic function, remodelling, and clinical outcomes among patients with diabetes following myocardial infarction and the influence of direct renin inhibition with aliskiren

    Article • European Journal of Heart Failure, February 2012, Wiley

    Professor john j mcmurray

  370. Microvolt T-Wave Alternans Testing Has No Role at Present in Guiding Therapy for Patients at High Risk of Ventricular Arrhythmias

    Article • Journal of the American College of Cardiology, February 2012, Elsevier

    Professor john j mcmurray

  371. Heart failure in 2011: Heart failure therapy—technology to the fore

    Article • Nature Reviews Cardiology, January 2012, Nature

    Professor john j mcmurray

  372. Assessment of Long-Term Effects of Irbesartan on Heart Failure With Preserved Ejection Fraction as Measured by the Minnesota Living With Heart Failure Questionnaire in the Irbesartan in Heart Failure With Preserved Systolic Function (I-PRESERVE) Trial

    Article • Circulation Heart Failure, January 2012, Wolters Kluwer Health

    Professor john j mcmurray

  373. The association between neutrophil gelatinase-associated lipocalin and clinical outcome in chronic heart failure: results from CORONA*

    Article • Journal of Internal Medicine, January 2012, Wiley

    Professor john j mcmurray

  374. Heart Failure

    Article • January 2012, Elsevier

    Professor john j mcmurray

  375. Predictors of cardiovascular events in a contemporary population with impaired glucose tolerance: an observational analysis of the Nateglinide and Valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trial

    Article • BMJ Open, January 2012, BMJ

    Professor john j mcmurray

  376. Aldosterone and cortisol predict medium-term left ventricular remodelling following myocardial infarction

    Article • European Journal of Heart Failure, December 2011, Wiley

    Professor john j mcmurray

  377. Stroke in Patients With Type 2 Diabetes Mellitus, Chronic Kidney Disease, and Anemia Treated With Darbepoetin Alfa: The Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT) Experience

    Article • Circulation, November 2011, Wolters Kluwer Health

    Professor john j mcmurray

  378. Pharmacist intervention in primary care to improve outcomes in patients with left ventricular systolic dysfunction

    Article • European Heart Journal, November 2011, European Society of Cardiology

    Professor john j mcmurray

  379. Prevalence and Significance of Alterations in Cardiac Structure and Function in Patients With Heart Failure and a Preserved Ejection Fraction

    Article • Circulation, November 2011, Wolters Kluwer Health

    Professor john j mcmurray

  380. Calcium Handling in the Failing Heart and SUMO — Weighing the Evidence

    Article • New England Journal of Medicine, November 2011, New England Journal of Medicine (NEJM/MMS)

    Professor john j mcmurray

  381. Days alive and out of hospital and the patient journey in patients with heart failure: Insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program

    Article • American Heart Journal, November 2011, Elsevier

    Professor john j mcmurray, Professor John GF Cleland

  382. Intensive glycemic control has no impact on the risk of heart failure in type 2 diabetic patients: Evidence from a 37,229 patient meta-analysis

    Article • American Heart Journal, November 2011, Elsevier

    Prof. Giuseppe Biondi-Zoccai, Professor john j mcmurray

  383. Association Between Cardiac Biomarkers and the Development of ESRD in Patients With Type 2 Diabetes Mellitus, Anemia, and CKD

    Article • American Journal of Kidney Diseases, November 2011, Elsevier

    Professor john j mcmurray

  384. Cardiac structure and function, remodeling, and clinical outcomes among patients with diabetes after myocardial infarction complicated by left ventricular systolic dysfunction, heart failure, or both

    Article • American Heart Journal, October 2011, Elsevier

    Professor john j mcmurray

  385. Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: An analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT)

    Article • American Heart Journal, October 2011, Elsevier

    Professor john j mcmurray

  386. Apixaban versus Warfarin in Patients with Atrial Fibrillation

    Article • New England Journal of Medicine, September 2011, New England Journal of Medicine (NEJM/MMS)

    Professor john j mcmurray, Job Harenberg

  387. CONSENSUS to EMPHASIS: the overwhelming evidence which makes blockade of the renin-angiotensin-aldosterone system the cornerstone of therapy for systolic heart failure

    Article • European Journal of Heart Failure, September 2011, Wiley

    Professor john j mcmurray

  388. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries * The Task Force on the Diagnosis and Tr...

    Article • European Heart Journal, August 2011, European Society of Cardiology

    Professor john j mcmurray

  389. The Heart failure and Optimal Outcomes from Pharmacy Study (HOOPS): rationale, design, and baseline characteristics

    Article • European Journal of Heart Failure, August 2011, Wiley

    Professor Frances S Mair, Professor john j mcmurray

  390. The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial

    Article • The Lancet, August 2011, Elsevier

    Professor john j mcmurray, Professor John GF Cleland

  391. Effect of Aliskiren in Patients with Heart Failure According to Background Dose of ACE Inhibitor: A Retrospective Analysis of the Aliskiren Observation of Heart Failure Treatment (ALOFT) Trial

    Article • Cardiovascular Drugs and Therapy, July 2011, Springer Science + Business Media

    Professor john j mcmurray

  392. Relation of Peripheral Collagen Markers to Death and Hospitalization in Patients With Heart Failure and Preserved Ejection Fraction: Results of the I-PRESERVE Collagen Substudy

    Article • Circulation Heart Failure, July 2011, Wolters Kluwer Health

    Professor john j mcmurray

  393. Effect of Nesiritide in Patients with Acute Decompensated Heart Failure

    Article • New England Journal of Medicine, July 2011, New England Journal of Medicine (NEJM/MMS)

    Professor john j mcmurray

  394. Heart Failure

    Article • Journal of the American College of Cardiology, July 2011, Elsevier

    Professor john j mcmurray

  395. Associations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study

    Article • European Journal of Heart Failure, July 2011, Wiley

    Professor john j mcmurray

  396. Neurohumoral effects of aliskiren in patients with symptomatic heart failure receiving a mineralocorticoid receptor antagonist: the Aliskiren Observation of Heart Failure Treatment study

    Article • European Journal of Heart Failure, July 2011, Wiley

    Professor john j mcmurray

  397. Prognostic Value of Baseline Plasma Amino-Terminal Pro-Brain Natriuretic Peptide and Its Interactions With Irbesartan Treatment Effects in Patients With Heart Failure and Preserved Ejection Fraction: Findings From the I-PRESERVE Trial

    Article • Circulation Heart Failure, June 2011, Wolters Kluwer Health

    Professor john j mcmurray, Professor John GF Cleland

  398. Incremental value of echocardiographic assessment beyond clinical evaluation for prediction of death and development of heart failure after high-risk myocardial infarction

    Article • American Heart Journal, June 2011, Elsevier

    Professor john j mcmurray

  399. Plasma TIMP-4 Predicts Left Ventricular Remodeling After Acute Myocardial Infarction

    Article • Journal of Cardiac Failure, June 2011, Elsevier

    Professor john j mcmurray

  400. Circumstances and Outcomes of Sudden Unexpected Death in Patients With High-Risk Myocardial Infarction: Implications for Prevention

    Article • Circulation, May 2011, Wolters Kluwer Health

    Professor john j mcmurray

  401. Incidence and Prevalence of Unrecognized Myocardial Infarction in People With Diabetes: A substudy of the Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycemia in Diabetes (RECORD) study

    Article • Diabetes Care, May 2011, American Diabetes Association

    Professor john j mcmurray

  402. Response to Letter Regarding Article, "Pathogenesis of Sudden Unexpected Death in a Clinical Trial of Patients With Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both"

    Article • Circulation, May 2011, Wolters Kluwer Health

    Professor john j mcmurray

  403. Heart Failure and Chronic Obstructive Pulmonary Disease

    Article • Journal of the American College of Cardiology, May 2011, Elsevier

    Professor john j mcmurray

  404. Preexposure Chemoprophylaxis for HIV Prevention

    Article • New England Journal of Medicine, April 2011, New England Journal of Medicine (NEJM/MMS)

    Professor john j mcmurray

  405. 'Iron deficiency: an ominous sign in patients with systolic chronic heart failure' [Eur Heart J 2010;31:1872-1880, doi:10.1093/eurheartj/ehq158]

    Article • European Heart Journal, April 2011, European Society of Cardiology

    Professor john j mcmurray

  406. Reply

    Article • Journal of the American College of Cardiology, April 2011, Elsevier

    Professor john j mcmurray

  407. Exercise training in heart failure: from theory to practice. A consensus document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation

    Article • European Journal of Heart Failure, April 2011, Wiley

    Professor john j mcmurray

  408. Trends in incidence and in short term survival following a subarachnoid haemorrhage in Scotland, 1986 - 2005: a retrospective cohort study

    Article • BMC Neurology, March 2011, Springer Science + Business Media

    Professor john j mcmurray

  409. Heart failure: Acute ischemic events in HF—should we include sudden death?

    Article • Nature Reviews Cardiology, February 2011, Nature

    Professor john j mcmurray

  410. Effect of the direct renin inhibitor aliskiren on left ventricular remodelling following myocardial infarction with systolic dysfunction

    Article • European Heart Journal, February 2011, European Society of Cardiology

    Professor john j mcmurray

  411. Clinical development of pharmacologic agents for acute heart failure syndromes: A proposal for a mechanistic translational phase

    Article • American Heart Journal, February 2011, Elsevier

    Professor john j mcmurray

  412. Clinical Trials Update AHA Congress 2010

    Article • Cardiovascular Drugs and Therapy, February 2011, Springer Science + Business Media

    Professor john j mcmurray

  413. Evaluation of the Functional Status Questionnaire in Heart Failure: A Sub-study of the Second Cardiac Insufficiency Bisoprolol Survival Study (CIBIS-II)

    Article • Cardiovascular Drugs and Therapy, February 2011, Springer Science + Business Media

    Professor john j mcmurray

  414. Predictors and prognostic impact of recurrent myocardial infarction in patients with left ventricular dysfunction, heart failure, or both following a first myocardial infarction

    Article • European Journal of Heart Failure, February 2011, Wiley

    Professor john j mcmurray

  415. Self-care management of heart failure: practical recommendations from the Patient Care Committee of the Heart Failure Association of the European Society of Cardiology

    Article • European Journal of Heart Failure, February 2011, Wiley

    Professor john j mcmurray

  416. Darbepoetin Alfa Impact on Health Status in Diabetes Patients with Kidney Disease: A Randomized Trial

    Article • Clinical Journal of the American Society of Nephrology, January 2011, American Society of Nephrology

    Professor john j mcmurray

  417. Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

    Article • New England Journal of Medicine, January 2011, New England Journal of Medicine (NEJM/MMS)

    Professor john j mcmurray

  418. A systematic review of event rates in clinical trials in diabetes mellitus: The importance of quantifying baseline cardiovascular disease history and proteinuria and implications for clinical trial design

    Article • American Heart Journal, January 2011, Elsevier

    Professor john j mcmurray

  419. 40 Angiotensin receptor blockers

    Article • January 2011, Oxford University Press (OUP)

    Professor john j mcmurray

  420. Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE (ATMOS

    Article • European Journal of Heart Failure, January 2011, Wiley

    Professor john j mcmurray

  421. Neurohormonal Activation in Acute Heart Failure: Results from VERITAS

    Article • Cardiology, January 2011, Karger Publishers

    Professor john j mcmurray

  422. Factors Associated With Outcome in Heart Failure With Preserved Ejection Fraction: Findings From the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-PRESERVE)

    Article • Circulation Heart Failure, November 2010, Wolters Kluwer Health

    Professor john j mcmurray

  423. Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial

    Article • Heart, November 2010, BMJ

    Professor john j mcmurray

  424. 2010 Focused Update of ESC Guidelines on device therapy in heart failure

    Article • EP Europace, November 2010, European Society of Cardiology

    Professor john j mcmurray

  425. 2010 Focused Update of ESC Guidelines on device therapy in heart failure

    Article • European Journal of Heart Failure, November 2010, Wiley

    Professor john j mcmurray

  426. Longitudinal and Circumferential Strain Rate, Left Ventricular Remodeling, and Prognosis After Myocardial Infarction

    Article • Journal of the American College of Cardiology, November 2010, Elsevier

    Professor john j mcmurray

  427. The inter-relationship of diabetes and left ventricular systolic function on outcome after high-risk myocardial infarction

    Article • European Journal of Heart Failure, November 2010, Wiley

    Professor john j mcmurray

  428. Guidelines for the management of atrial fibrillation

    Article • EP Europace, October 2010, European Society of Cardiology

    Professor john j mcmurray

  429. Coenzyme Q10, Rosuvastatin, and Clinical Outcomes in Heart Failure

    Article • Journal of the American College of Cardiology, October 2010, Elsevier

    Professor john j mcmurray, Professor John GF Cleland

  430. Erythropoietic Response and Outcomes in Kidney Disease and Type 2 Diabetes

    Article • New England Journal of Medicine, September 2010, New England Journal of Medicine (NEJM/MMS)

    Professor john j mcmurray

  431. Impact of erythropoiesis-stimulating agents on morbidity and mortality in patients with heart failure: an updated, post-TREAT meta-analysis

    Article • European Journal of Heart Failure, September 2010, Wiley

    Professor john j mcmurray

  432. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

    Article • European Heart Journal, August 2010, European Society of Cardiology

    Professor john j mcmurray

  433. 2010 Focused Update of ESC Guidelines on device therapy in heart failure: An update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy Deve...

    Article • European Heart Journal, August 2010, European Society of Cardiology

    Professor john j mcmurray

  434. Effect of Valsartan on the Incidence of Diabetes

    Article • New England Journal of Medicine, August 2010, New England Journal of Medicine (NEJM/MMS)

    Professor john j mcmurray

  435. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy

    Article • European Journal of Heart Failure, August 2010, Wiley

    Professor john j mcmurray

  436. Pathogenesis of Sudden Unexpected Death in a Clinical Trial of Patients With Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both

    Article • Circulation, July 2010, Wolters Kluwer Health

    Professor john j mcmurray

  437. Estimating the impact of stroke unit care in a whole population: an epidemiological study using routine data

    Article • Journal of Neurology Neurosurgery & Psychiatry, July 2010, BMJ

    Professor john j mcmurray

  438. Fatal myocardial rupture after acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: The VALsartan In Acute myocardial iNfarcTion Trial (VALIANT)

    Article • American Heart Journal, July 2010, Elsevier

    Professor john j mcmurray

  439. Efficacy and safety of angiotensin receptor blockade are not modified by aspirin in patients with chronic heart failure: a cohort study from the Candesartan in Heart failure - Assessment of Reduction in Mortality and morbidity (CHARM) programme

    Article • European Journal of Heart Failure, July 2010, Wiley

    Professor john j mcmurray

  440. Corrigendum to ‘Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trial’ [Eur J Heart Fail2009;11:795-801]

    Article • European Journal of Heart Failure, July 2010, Wiley

    Professor john j mcmurray

  441. Intermittent claudication as a predictor of outcome in patients with ischaemic systolic heart failure: analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure trial (CORONA)

    Article • European Journal of Heart Failure, July 2010, Wiley

    Professor john j mcmurray

  442. Iron deficiency: an ominous sign in patients with systolic chronic heart failure

    Article • European Heart Journal, June 2010, European Society of Cardiology

    Professor john j mcmurray

  443. Baseline characteristics and outcomes of patients with heart failure receiving bronchodilators in the CHARM programme

    Article • European Journal of Heart Failure, May 2010, Wiley

    Professor john j mcmurray

  444. Improved survival with bisoprolol in patients with heart failure and renal impairment: an analysis of the cardiac insufficiency bisoprolol study II (CIBIS-II) trial

    Article • European Journal of Heart Failure, May 2010, Wiley

    Professor john j mcmurray

  445. Rationale and design of the Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure (EMPHASIS-HF)

    Article • European Journal of Heart Failure, May 2010, Wiley

    Professor john j mcmurray

  446. Monocyte chemoattractant protein-1: A dichotomous role in cardiac remodeling following acute myocardial infarction in man?

    Article • Cytokine, May 2010, Elsevier

    Professor john j mcmurray

  447. Effect of Nateglinide on the Incidence of Diabetes and Cardiovascular Events

    Article • New England Journal of Medicine, April 2010, New England Journal of Medicine (NEJM/MMS)

    Professor john j mcmurray

  448. Effect of Valsartan on the Incidence of Diabetes and Cardiovascular Events

    Article • New England Journal of Medicine, April 2010, New England Journal of Medicine (NEJM/MMS)

    Professor john j mcmurray

  449. Systolic Heart Failure

    Article • New England Journal of Medicine, April 2010, New England Journal of Medicine (NEJM/MMS)

    Professor john j mcmurray

  450. Assessing and grading congestion in acute heart failure: a scientific statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine

    Article • European Journal of Heart Failure, April 2010, Wiley

    Professor john j mcmurray, Professor John GF Cleland

  451. Atrial fibrillation management strategies and early mortality after myocardial infarction: results from the Valsartan in Acute Myocardial Infarction (VALIANT) Trial

    Article • Heart, April 2010, BMJ

    Professor john j mcmurray

  452. Temporal trends in hospitalisation for stroke recurrence following incident hospitalisation for stroke in Scotland

    Article • BMC Medicine, April 2010, Springer Science + Business Media

    Professor john j mcmurray

  453. Reply

    Article • Journal of the American College of Cardiology, April 2010, Elsevier

    Professor john j mcmurray, Professor John GF Cleland

  454. Baseline Characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial Population: Comparison with Other Diabetes Prevention Trials

    Article • Cardiovascular Therapeutics, April 2010, Wiley

    Professor john j mcmurray

  455. Potentially detrimental cardiovascular effects of oxygen in patients with chronic left ventricular systolic dysfunction

    Article • Heart, March 2010, BMJ

    Professor john j mcmurray

  456. Microvascular Obstruction Remains a Portent of Adverse Remodeling in Optimally Treated Patients With Left Ventricular Systolic Dysfunction After Acute Myocardial Infarction

    Article • Circulation Cardiovascular Imaging, March 2010, Wolters Kluwer Health

    Professor john j mcmurray

  457. Corrigendum to ‘ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008’ [Eur Heart J 2008;29:2388-2442 and Eur J Heart Fail 2008;10:933-989]

    Article • European Journal of Heart Failure, March 2010, Wiley

    Professor john j mcmurray

  458. Evaluation of Bromocriptine in the Treatment of Acute Severe Peripartum Cardiomyopathy: A Proof-of-Concept Pilot Study

    Article • Circulation, March 2010, Wolters Kluwer Health

    Professor john j mcmurray, Jan-Peter Smedema

  459. Treatment of Type 2 Diabetes and Outcomes in Patients With Heart Failure: A Nested Case-Control Study From the U.K. General Practice Research Database

    Article • Diabetes Care, March 2010, American Diabetes Association

    Professor john j mcmurray

  460. Mode of Death in Patients With Heart Failure and a Preserved Ejection Fraction: Results From the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) Trial

    Article • Circulation, March 2010, Wolters Kluwer Health

    Professor john j mcmurray

  461. Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale

    Article • American Heart Journal, March 2010, Elsevier

    Professor john j mcmurray

  462. Corrigendum to: ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collabora...

    Article • European Heart Journal, March 2010, European Society of Cardiology

    Professor john j mcmurray

  463. Clinical Trials of Pharmacological Therapies in Acute Heart Failure Syndromes: Lessons Learned and Directions Forward

    Article • Circulation Heart Failure, March 2010, Wolters Kluwer Health

    Professor john j mcmurray, Professor John GF Cleland

  464. Event Rates in Trials of Patients With Type 2 Diabetes

    Article • JAMA, February 2010, American Medical Association (AMA)

    Professor john j mcmurray

  465. Evaluating dyspnoea in acute heart failure: progress at last!

    Article • European Heart Journal, February 2010, European Society of Cardiology

    Professor john j mcmurray

  466. Heart Failure: Hospital-at-home care for CHF—verdict, 'not proven'

    Article • Nature Reviews Cardiology, February 2010, Nature

    Professor john j mcmurray

  467. Baseline Plasma NT-proBNP and Clinical Characteristics: Results From the Irbesartan in Heart Failure With Preserved Ejection Fraction Trial

    Article • Journal of Cardiac Failure, February 2010, Elsevier

    Professor john j mcmurray

  468. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

    Article • The Lancet, February 2010, Elsevier

    Professor john j mcmurray

  469. Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial

    Article • European Heart Journal, January 2010, European Society of Cardiology

    Professor john j mcmurray

  470. Systolic Heart Failure

    Article • New England Journal of Medicine, January 2010, New England Journal of Medicine (NEJM/MMS)

    Professor john j mcmurray

  471. HEAAL: the final chapter in the story of angiotensin receptor blockers in heart failure-lessons learnt from a decade of trials

    Article • European Journal of Heart Failure, January 2010, Wiley

    Professor john j mcmurray

  472. Serum Soluble ST2

    Article • Journal of the American College of Cardiology, January 2010, Elsevier

    Professor john j mcmurray

  473. An economic evaluation of rosuvastatin treatment in systolic heart failure: evidence from the CORONA trial

    Article • European Journal of Heart Failure, December 2009, Wiley

    Professor john j mcmurray

  474. Primary care burden and treatment of patients with heart failure and chronic obstructive pulmonary disease in Scotland

    Article • European Journal of Heart Failure, December 2009, Wiley

    Professor john j mcmurray, Professor Colin R Simpson

  475. Rationale and design of the dal-OUTCOMES trial: Efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome

    Article • American Heart Journal, December 2009, Elsevier

    Professor john j mcmurray

  476. A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease

    Article • New England Journal of Medicine, November 2009, New England Journal of Medicine (NEJM/MMS)

    Professor john j mcmurray

  477. Red cell distribution width has incremental prognostic value to B-type natriuretic peptide in acute heart failure

    Article • European Journal of Heart Failure, November 2009, Wiley

    Professor john j mcmurray

  478. Effects of Statin Therapy According to Plasma High-Sensitivity C-Reactive Protein Concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): A Retrospective Analysis

    Article • Circulation, November 2009, Wolters Kluwer Health

    Professor john j mcmurray

  479. Plasma Concentration of Amino-Terminal Pro-Brain Natriuretic Peptide in Chronic Heart Failure: Prediction of Cardiovascular Events and Interaction With the Effects of Rosuvastatin

    Article • Journal of the American College of Cardiology, November 2009, Elsevier

    Professor john j mcmurray, Professor John GF Cleland

  480. Adherence to medication according to sex and age in the CHARM programme

    Article • European Journal of Heart Failure, October 2009, Wiley

    Professor john j mcmurray

  481. Predictors of sudden cardiac death change with time after myocardial infarction: results from the VALIANT trial

    Article • European Heart Journal, October 2009, European Society of Cardiology

    Professor john j mcmurray

  482. Aldosterone status associated with insulin resistance in patients with heart failure--data from the ALOFT study

    Article • Heart, August 2009, BMJ

    Professor john j mcmurray

  483. The prognostic significance of heart failure with preserved left ventricular ejection fraction: a literature-based meta-analysis

    Article • European Journal of Heart Failure, August 2009, Wiley

    Professor john j mcmurray

  484. Albuminuria in chronic heart failure: prevalence and prognostic importance

    Article • The Lancet, August 2009, Elsevier

    Professor john j mcmurray

  485. Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trial

    Article • European Journal of Heart Failure, July 2009, Wiley

    Professor Rajamani Krishna, Professor john j mcmurray

  486. Age- and Sex-Specific Trends in Fatal Incidence and Hospitalized Incidence of Stroke in Scotland, 1986 to 2005

    Article • Circulation Cardiovascular Quality and Outcomes, July 2009, Wolters Kluwer Health

    Professor john j mcmurray

  487. Baseline Characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)

    Article • American Journal of Kidney Diseases, July 2009, Elsevier

    Professor john j mcmurray

  488. Dual Renin-Angiotensin System Blockade and Kidney Disease

    Article • Journal of the American College of Cardiology, July 2009, Elsevier

    Professor john j mcmurray

  489. Dual Renin-Angiotensin System Blockade in Heart Failure

    Article • Journal of the American College of Cardiology, July 2009, Elsevier

    Professor john j mcmurray

  490. Usefulness of Beta Blockers in High-Risk Patients After Myocardial Infarction in Conjunction With Captopril and/or Valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] Trial)

    Article • The American Journal of Cardiology, July 2009, Elsevier

    Professor john j mcmurray

  491. Gastrointestinal bleeding in high risk survivors of myocardial infarction: the VALIANT Trial

    Article • European Heart Journal, June 2009, European Society of Cardiology

    Professor john j mcmurray

  492. Bisoprolol in patients with heart failure and moderate to severe chronic obstructive pulmonary disease: a randomized controlled trial

    Article • European Journal of Heart Failure, June 2009, Wiley

    Professor john j mcmurray

  493. Left ventricular remodeling after acute myocardial infarction: Does eplerenone have an effect?

    Article • American Heart Journal, June 2009, Elsevier

    Professor john j mcmurray

  494. Phase III clinical trial end points in acute heart failure syndromes: A virtual roundtable with the acute heart failure syndromes international working group

    Article • American Heart Journal, June 2009, Elsevier

    Professor john j mcmurray, Professor John GF Cleland

  495. Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial

    Article • The Lancet, June 2009, Elsevier

    Professor john j mcmurray

  496. Pharmacologic management of patients with both heart failure and diabetes

    Article • Current Heart Failure Reports, May 2009, Springer Science + Business Media

    Professor john j mcmurray

  497. Heart failure and chronic obstructive pulmonary disease: lung function test interpretation: reply

    Article • European Journal of Heart Failure, May 2009, Wiley

    Professor john j mcmurray

  498. Plasma apelin concentration is depressed following acute myocardial infarction in man

    Article • European Journal of Heart Failure, May 2009, Wiley

    Professor john j mcmurray

  499. Selecting Patients for Cardiac Resynchronization Therapy

    Article • Journal of the American College of Cardiology, May 2009, Elsevier

    Professor john j mcmurray

  500. Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology

    Article • European Journal of Heart Failure, April 2009, Wiley

    Professor john j mcmurray

  501. Should beta-blockade continue to be withheld from patients with chronic heart failure and asthma?: reply

    Article • European Heart Journal, April 2009, European Society of Cardiology

    Professor john j mcmurray

  502. Patients with prior coronary artery bypass grafting have a poor outcome after myocardial infarction: an analysis of the VALsartan in acute myocardial iNfarcTion trial (VALIANT)

    Article • European Heart Journal, April 2009, European Society of Cardiology

    Professor john j mcmurray

  503. Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT)

    Article • European Journal of Heart Failure, February 2009, Wiley

    Professor john j mcmurray

  504. Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide

    Article • European Journal of Heart Failure, February 2009, Wiley

    Professor john j mcmurray, Professor John GF Cleland

  505. Sex Differences in Incidence, Mortality, and Survival in Individuals With Stroke in Scotland, 1986 to 2005

    Article • Stroke, February 2009, Wolters Kluwer Health

    Professor john j mcmurray

  506. Predictors of Development of Diabetes in Patients With Chronic Heart Failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program

    Article • Diabetes Care, February 2009, American Diabetes Association

    Professor john j mcmurray

  507. Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF)

    Article • American Heart Journal, February 2009, Elsevier

    Professor john j mcmurray

  508. Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology

    Article • European Journal of Heart Failure, January 2009, Wiley

    Professor john j mcmurray

  509. Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology

    Article • European Journal of Heart Failure, January 2009, Wiley

    Professor john j mcmurray

  510. Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program

    Article • European Journal of Heart Failure, January 2009, Wiley

    Professor john j mcmurray

  511. Long-Term Trends in First Hospitalization for Heart Failure and Subsequent Survival Between 1986 and 2003: A Population Study of 5.1 Million People

    Article • Circulation, January 2009, Wolters Kluwer Health

    Professor john j mcmurray, Professor Colin R Simpson

  512. Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design

    Article • Nephrology Dialysis Transplantation, January 2009, Oxford University Press (OUP)

    Professor john j mcmurray

  513. What Works In Chronic Care Management: The Case Of Heart Failure

    Article • Health Affairs, January 2009, Health Affairs

    Professor john j mcmurray

  514. Heart Failure

    Article • January 2009, Oxford University Press (OUP)

    Professor john j mcmurray

  515. Cardiac and Extracardiac Abnormalities Detected by Cardiac Magnetic Resonance in a Post-Myocardial Infarction Cohort

    Article • Cardiology, January 2009, Karger Publishers

    Professor john j mcmurray

  516. Corrigendum to ‘ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008’ [Eur Heart J 2008;29:2388-2442 and Eur J Heart Fail 2008;10:933-989]

    Article • European Journal of Heart Failure, January 2009, Wiley

    Professor john j mcmurray

  517. Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction

    Article • New England Journal of Medicine, December 2008, New England Journal of Medicine (NEJM/MMS)

    Professor john j mcmurray, Professor Thierry C Gillebert, Professor Thomas Munzel or Muenzel, Massimo Volpe

  518. Biomarkers in heart failure: a clinical review

    Article • Heart Failure Reviews, December 2008, Springer Science + Business Media

    Professor john j mcmurray

  519. Predominance of Heart Failure in the Heart of Soweto Study Cohort: Emerging Challenges for Urban African Communities

    Article • Circulation, December 2008, Wolters Kluwer Health

    Professor john j mcmurray

  520. Corrigendum to ‘ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008’[Eur Heart J 2008;29:2388–2442 and Eur J Heart Fail 2008;10:933–989]

    Article • European Heart Journal, December 2008, European Society of Cardiology

    Professor john j mcmurray

  521. Medical management of advanced heart failure

    Article • Progress in Palliative Care, December 2008, Taylor & Francis

    Professor john j mcmurray

  522. Clinical Outcomes According to Baseline Blood Pressure in Patients With a Low Ejection Fraction in the CHARM (Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity) Program

    Article • Journal of the American College of Cardiology, December 2008, Elsevier

    Professor john j mcmurray

  523. Heart Failure After Acute Myocardial Infarction: A Lost Battle in the War on Heart Failure?

    Article • Circulation, November 2008, Wolters Kluwer Health

    Professor john j mcmurray

  524. Benefits and safety of candesartan treatment in heart failure are independent of age: insights from the Candesartan in Heart failure--Assessment of Reduction in Mortality and morbidity programme

    Article • European Heart Journal, November 2008, European Society of Cardiology

    Professor john j mcmurray

  525. Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: Rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial

    Article • American Heart Journal, October 2008, Elsevier

    Professor john j mcmurray

  526. Determining the most appropriate components for a composite clinical trial outcome

    Article • American Heart Journal, October 2008, Elsevier

    Professor john j mcmurray

  527. Diabetic Cardiology. Edited by Miles Fisher and John J McMurray. © 2007, John Wiley & Sons Ltd ISBN: 978 0 470 862049. Website: www.wiley.com

    Article • Practical Diabetes International, October 2008, Wiley

    Professor john j mcmurray

  528. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008‡

    Article • European Journal of Heart Failure, October 2008, Wiley

    Professor john j mcmurray

  529. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the He...

    Article • European Heart Journal, September 2008, European Society of Cardiology

    Professor john j mcmurray

  530. Impact of hospitalization for acute coronary events on subsequent mortality in patients with chronic heart failure

    Article • European Heart Journal, September 2008, European Society of Cardiology

    Professor john j mcmurray

  531. Prognostic Implications of Left Ventricular Mass and Geometry Following Myocardial Infarction

    Article • JACC Cardiovascular Imaging, September 2008, Elsevier

    Professor john j mcmurray

  532. The Hemoglobin A1c Level as a Progressive Risk Factor for Cardiovascular Death, Hospitalization for Heart Failure, or Death in Patients With Chronic Heart Failure

    Article • Archives of Internal Medicine, August 2008, American Medical Association (AMA)

    Professor john j mcmurray

  533. Extracellular Matrix Turnover and Inflammatory Markers Independently Predict Functional Status and Outcome in Chronic Heart Failure

    Article • Journal of Cardiac Failure, August 2008, Elsevier

    Professor john j mcmurray

  534. Left atrial remodelling in patients with myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALIANT Echo Study

    Article • European Heart Journal, July 2008, European Society of Cardiology

    Professor john j mcmurray

  535. Anesthesia Awareness and the Bispectral Index

    Article • New England Journal of Medicine, July 2008, New England Journal of Medicine (NEJM/MMS)

    Professor john j mcmurray

  536. Heart Failure—Optimal Pharmacological Therapy

    Article • July 2008, Oxford University Press (OUP)

    Professor john j mcmurray

  537. Response to Letter Regarding Article, "Influence of Nonfatal Hospitalization for Heart Failure on Subsequent Mortality in Patients With Chronic Heart Failure"

    Article • Circulation, July 2008, Wolters Kluwer Health

    Professor john j mcmurray

  538. Increased Mortality after Dronedarone Therapy for Severe Heart Failure

    Article • New England Journal of Medicine, June 2008, New England Journal of Medicine (NEJM/MMS)

    Professor john j mcmurray

  539. Awareness and perception of heart failure among European cardiologists, internists, geriatricians, and primary care physicians

    Article • European Heart Journal, June 2008, European Society of Cardiology

    Professor john j mcmurray

  540. Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme

    Article • European Heart Journal, May 2008, European Society of Cardiology

    Professor john j mcmurray

  541. How should we optimize cardiac resynchronization therapy?

    Article • European Heart Journal, May 2008, European Society of Cardiology

    Professor john j mcmurray

  542. Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial

    Article • The Lancet, May 2008, Elsevier

    Professor john j mcmurray

  543. Long-term outcome of low-risk patients attending a rapid-assessment chest pain clinic

    Article • Heart, May 2008, BMJ

    Professor john j mcmurray

  544. Racial Analysis of Patients With Myocardial Infarction Complicated by Heart Failure and/or Left Ventricular Dysfunction Treated With Valsartan, Captopril, or Both

    Article • Journal of the American College of Cardiology, May 2008, Elsevier

    Professor john j mcmurray

  545. Diabetes, left ventricular systolic dysfunction, and chronic heart failure

    Article • European Heart Journal, April 2008, European Society of Cardiology

    Professor john j mcmurray

  546. ACE Inhibitors in Cardiovascular Disease — Unbeatable?

    Article • New England Journal of Medicine, April 2008, New England Journal of Medicine (NEJM/MMS)

    Professor john j mcmurray

  547. Approaches to the treatment of anaemia in patients with chronic heart failure

    Article • Heart Failure Reviews, April 2008, Springer Science + Business Media

    Professor john j mcmurray

  548. High-risk myocardial infarction in the young: The VALsartan In Acute myocardial iNfarcTion (VALIANT) trial

    Article • American Heart Journal, April 2008, Elsevier

    Professor john j mcmurray

  549. Comparison of Renal Function and Cardiovascular Risk Following Acute Myocardial Infarction in Patients With and Without Diabetes Mellitus

    Article • The American Journal of Cardiology, April 2008, Elsevier

    Professor john j mcmurray

  550. Response to The J-Point Revisited

    Article • Hypertension, March 2008, Wolters Kluwer Health

    Professor john j mcmurray

  551. Rosuvastatin in Older Patients with Systolic Heart Failure

    Article • New England Journal of Medicine, March 2008, New England Journal of Medicine (NEJM/MMS)

    Professor john j mcmurray

  552. Nature and prognostic importance of abnormal glucose tolerance and diabetes in acute heart failure

    Article • Heart, March 2008, BMJ

    Professor john j mcmurray

  553. Usefulness of Right Ventricular Fractional Area Change to Predict Death, Heart Failure, and Stroke Following Myocardial Infarction (from the VALIANT ECHO Study)

    Article • The American Journal of Cardiology, March 2008, Elsevier

    Professor john j mcmurray

  554. Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT study

    Article • European Heart Journal, February 2008, European Society of Cardiology

    Professor john j mcmurray

  555. Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart fa

    Article • European Journal of Heart Failure, February 2008, Wiley

    Professor john j mcmurray

  556. Heart failure with preserved ejection fraction: Clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial

    Article • European Journal of Heart Failure, February 2008, Wiley

    Professor john j mcmurray

  557. Prognostic impact of pulmonary arterial hypertension: A population-based analysis

    Article • International Journal of Cardiology, February 2008, Elsevier

    Professor john j mcmurray

  558. Transthoracic echocardiography: a survey of current practice in the UK

    Article • QJM, January 2008, Oxford University Press (OUP)

    Professor john j mcmurray

  559. The complex nature of informal care in home-based heart failure management

    Article • Journal of Advanced Nursing, January 2008, Wiley

    Professor john j mcmurray

  560. Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: An analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme

    Article • European Heart Journal, January 2008, European Society of Cardiology

    Professor john j mcmurray

  561. Amiodarone use after acute myocardial infarction complicated by heart failure and/or left ventricular dysfunction may be associated with excess mortality

    Article • American Heart Journal, January 2008, Elsevier

    Professor john j mcmurray

  562. A randomised trial of a pre-synaptic stimulator of DA2-dopaminergic and α2-adrenergic receptors on morbidity and mortality in patients with heart failure

    Article • European Journal of Heart Failure, January 2008, Wiley

    Professor john j mcmurray

  563. Is Microvolt T-Wave Alternans the Answer to Risk Stratification in Heart Failure?

    Article • Circulation, December 2007, Wolters Kluwer Health

    Professor john j mcmurray

  564. Diabetic Cardiology

    Article • December 2007, Wiley

    Professor john j mcmurray

  565. S40-5 CURRENT AND FUTURE TREATMENT OPTIONS IN HEART FAILURE WITH PRESERVED SYSTOLIC FUNCTION

    Article • International Journal of Cardiology, December 2007, Elsevier

    Professor john j mcmurray

  566. Rosuvastatin in Older Patients with Systolic Heart Failure

    Article • New England Journal of Medicine, November 2007, New England Journal of Medicine (NEJM/MMS)

    Professor john j mcmurray, Professor John GF Cleland

  567. Effect of Antecedent Hypertension and Follow-Up Blood Pressure on Outcomes After High-Risk Myocardial Infarction

    Article • Hypertension, November 2007, Wolters Kluwer Health

    Professor john j mcmurray

  568. Clinical Trials Update from the European Society of Cardiology Congress in Vienna, 2007: PROSPECT, EVEREST, ARISE, ALOFT, FINESSE, Prague-8, CARESS in MI and ACUITY

    Article • Cardiovascular Drugs and Therapy, November 2007, Springer Science + Business Media

    Professor john j mcmurray

  569. Effects of Tezosentan on Symptoms and Clinical Outcomes in Patients With Acute Heart Failure

    Article • JAMA, November 2007, American Medical Association (AMA)

    Professor john j mcmurray, Professor John GF Cleland

  570. Corrections

    Article • Heart, November 2007, BMJ

    Professor john j mcmurray

  571. Incidence and Predictors of Hyperkalemia in Patients With Heart Failure

    Article • Journal of the American College of Cardiology, November 2007, Elsevier

    Professor john j mcmurray

  572. Neurohumoral effects of the new orally active renin inhibitor, aliskiren, in chronic heart failure

    Article • European Journal of Heart Failure, November 2007, Wiley

    Professor john j mcmurray

  573. Corrigendum to “Effects of aldosterone receptor blockade in patients with mild-moderate heart failure taking a beta-blocker” [European Journal of Heart Failure 9/4 (2007) 429-434]

    Article • European Journal of Heart Failure, October 2007, Wiley

    Professor john j mcmurray

  574. Influence of Nonfatal Hospitalization for Heart Failure on Subsequent Mortality in Patients With Chronic Heart Failure

    Article • Circulation, September 2007, Wolters Kluwer Health

    Professor john j mcmurray

  575. The Relationship Between Renal Function and Cardiac Structure, Function, and Prognosis After Myocardial Infarction

    Article • Journal of the American College of Cardiology, September 2007, Elsevier

    Professor john j mcmurray

  576. Differences in arterial compliance, microvascular function and venous capacitance between patients with heart failure and either preserved or reduced left ventricular systolic function

    Article • European Journal of Heart Failure, August 2007, Wiley

    Professor john j mcmurray

  577. Body Mass Index and Prognosis in Patients With Chronic Heart Failure: Insights From the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) Program

    Article • Circulation, August 2007, Wolters Kluwer Health

    Professor john j mcmurray

  578. Rosiglitazone Evaluated for Cardiovascular Outcomes — An Interim Analysis

    Article • New England Journal of Medicine, July 2007, New England Journal of Medicine (NEJM/MMS)

    Professor john j mcmurray

  579. Red Cell Distribution Width as a Novel Prognostic Marker in Heart Failure

    Article • Journal of the American College of Cardiology, July 2007, Elsevier

    Professor john j mcmurray

  580. Sex Differences in Clinical Characteristics and Prognosis in a Broad Spectrum of Patients With Heart Failure: Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) Program

    Article • Circulation, June 2007, Wolters Kluwer Health

    Professor john j mcmurray

  581. Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology

    Article • European Journal of Heart Failure, May 2007, Wiley

    Professor john j mcmurray

  582. Heart failure: are we neglecting the silent majority?

    Article • European Heart Journal, May 2007, European Society of Cardiology

    Professor john j mcmurray

  583. A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland

    Article • Heart, May 2007, BMJ

    Professor john j mcmurray, Professor Colin R Simpson

  584. Prevalence and prognostic impact of bundle branch block in patients with heart failure: Evidence from the CHARM programme

    Article • European Journal of Heart Failure, April 2007, Wiley

    Professor john j mcmurray

  585. A Randomized, Placebo-Controlled Trial Assessing the Effects of Rosiglitazone on Echocardiographic Function and Cardiac Status in Type 2 Diabetic Patients With New York Heart Association Functional Class I or II Heart Failure

    Article • Journal of the American College of Cardiology, April 2007, Elsevier

    Professor john j mcmurray

  586. Response to Letter Regarding Article, "Effect of Celecoxib on Cardiovascular Events and Blood Pressure in Two Trials for the Prevention of Colorectal Adenomas"

    Article • Circulation, March 2007, Wolters Kluwer Health

    Professor john j mcmurray

  587. Effects of aldosterone receptor blockade in patients with mild-moderate heart failure taking a beta-blocker

    Article • European Journal of Heart Failure, March 2007, Wiley

    Professor john j mcmurray

  588. Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide

    Article • European Heart Journal, March 2007, European Society of Cardiology

    Professor john j mcmurray

  589. Dysglycemia and Heart Failure Hospitalization: What Is the Link?

    Article • Circulation, March 2007, Wolters Kluwer Health

    Professor john j mcmurray

  590. An epidemiological study of pulmonary arterial hypertension

    Article • European Respiratory Journal, March 2007, European Respiratory Society (ERS)

    Professor john j mcmurray

  591. Long-term outcomes of left bundle branch block in high-risk survivors of acute myocardial infarction: The VALIANT experience

    Article • Heart Rhythm, March 2007, Elsevier

    Professor john j mcmurray

  592. Reply

    Article • Journal of the American College of Cardiology, February 2007, Elsevier

    Professor john j mcmurray

  593. Are erythropoietin stimulating proteins safe and efficacious in heart failure? Why we need an adequately powered randomised outcome trial

    Article • European Journal of Heart Failure, February 2007, Wiley

    Professor john j mcmurray

  594. Mitral regurgitation in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: prognostic significance and relation to ventricular size and function

    Article • European Heart Journal, January 2007, European Society of Cardiology

    Professor john j mcmurray

  595. Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM

    Article • European Journal of Heart Failure, January 2007, Wiley

    Professor john j mcmurray

  596. Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programme

    Article • Heart, January 2007, BMJ

    Professor john j mcmurray

  597. Epidemiology of heart failure and left ventricular dysfunction after acute myocardial infarction

    Article • Current Heart Failure Reports, December 2006, Springer Science + Business Media

    Professor john j mcmurray

  598. A population study of the long-term consequences of Rose angina: 20-year follow-up of the Renfrew-Paisley study

    Article • Heart, December 2006, BMJ

    Professor john j mcmurray

  599. Effect of socioeconomic deprivation on the population risk of incident heart failure hospitalisation: An analysis of the Renfrew/Paisley Study

    Article • European Journal of Heart Failure, November 2006, Wiley

    Professor john j mcmurray

  600. Short-term and long-term outcomes in 133 429 emergency patients admitted with angina or myocardial infarction in Scotland, 1990-2000: population-based cohort study

    Article • Heart, November 2006, BMJ

    Professor john j mcmurray

  601. Renin angiotensin blockade in heart failure with preserved ejection fraction: the signal gets stronger

    Article • European Heart Journal, October 2006, European Society of Cardiology

    Professor john j mcmurray

  602. Aldosterone blockade in post-acute myocardial infarction heart failure

    Article • Clinical Cardiology, October 2006, Wiley

    Professor john j mcmurray

  603. Reply

    Article • Journal of the American College of Cardiology, October 2006, Elsevier

    Professor john j mcmurray

  604. Anaemia is an independent predictor of mortality in patients with left ventricular systolic dysfunction following acute myocardial infarction☆

    Article • European Journal of Heart Failure, October 2006, Wiley

    Professor john j mcmurray

  605. Previously known and newly diagnosed atrial fibrillation: A major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction☆

    Article • European Journal of Heart Failure, October 2006, Wiley

    Professor john j mcmurray

  606. Predictors of stroke in high-risk patients after acute myocardial infarction: insights from the VALIANT trial

    Article • European Heart Journal, September 2006, European Society of Cardiology

    Professor john j mcmurray

  607. Geographic variation in the treatment of acute myocardial infarction in the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial

    Article • American Heart Journal, September 2006, Elsevier

    Professor john j mcmurray

  608. Effect of Celecoxib on Cardiovascular Events and Blood Pressure in Two Trials for the Prevention of Colorectal Adenomas

    Article • Circulation, August 2006, Wolters Kluwer Health

    Professor john j mcmurray

  609. Treatment of chronic heart failure: a comparison between the major guidelines

    Article • European Heart Journal, August 2006, European Society of Cardiology

    Professor john j mcmurray

  610. Using Measures of Disease Progression to Determine Therapeutic Effect

    Article • Journal of the American College of Cardiology, August 2006, Elsevier

    Professor john j mcmurray

  611. Prevalence, incidence, primary care burden and medical treatment of angina in Scotland: age, sex and socioeconomic disparities: a population-based study

    Article • Heart, August 2006, BMJ

    Professor john j mcmurray, Professor Colin R Simpson

  612. Extent of coronary artery disease as a predictor of outcomes in acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

    Article • American Heart Journal, July 2006, Elsevier

    Professor john j mcmurray

  613. Does Aspirin Reduce the Benefit of an Angiotensin-Converting Enzyme Inhibitor?: Choosing Between the Scylla of Observational Studies and the Charybdis of Subgroup Analysis

    Article • Circulation, June 2006, Wolters Kluwer Health

    Professor john j mcmurray

  614. The prevalence, nature, and importance of hematologic abnormalities in heart failure

    Article • American Heart Journal, June 2006, Elsevier

    Professor john j mcmurray

  615. The treatment of heart failure with preserved ejection fraction (“diastolic heart failure”)

    Article • Heart Failure Reviews, June 2006, Springer Science + Business Media

    Professor john j mcmurray

  616. Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)–Added trial

    Article • American Heart Journal, May 2006, Elsevier

    Professor john j mcmurray

  617. Multifaceted intervention to promote β-blocker use in heart failure

    Article • American Heart Journal, May 2006, Elsevier

    Professor john j mcmurray

  618. Atrial Fibrillation and Risk of Clinical Events in Chronic Heart Failure With and Without Left Ventricular Systolic Dysfunction

    Article • Journal of the American College of Cardiology, May 2006, Elsevier

    Professor john j mcmurray

  619. Economic evaluation of the impact of nicorandil in angina (IONA) trial

    Article • Heart, May 2006, BMJ

    Professor john j mcmurray

  620. Epidemiology of Heart Failure and Left Ventricular Systolic Dysfunction after Acute Myocardial Infarction: Prevalence, Clinical Characteristics, and Prognostic Importance

    Article • The American Journal of Cardiology, May 2006, Elsevier

    Professor john j mcmurray

  621. Hospital burden of suspected acute coronary syndromes: recent trends

    Article • Heart, May 2006, BMJ

    Professor john j mcmurray

  622. QRS duration alone to select patients for cardiac resynchronization therapy: flying in the face of the evidence?

    Article • European Heart Journal, April 2006, European Society of Cardiology

    Professor john j mcmurray

  623. Patients strategies for managing medication for chronic heart failure

    Article • International Journal of Cardiology, April 2006, Elsevier

    Professor john j mcmurray

  624. Selecting patients for cardiac resynchronization therapy: electrical or mechanical dyssynchrony?

    Article • European Heart Journal, March 2006, European Society of Cardiology

    Professor john j mcmurray

  625. Chilling Findings: The Need for Winter Vigilance in Heart Failure

    Article • Journal of Cardiac Failure, March 2006, Elsevier

    Professor john j mcmurray

  626. Association of QRS duration and outcomes after myocardial infarction: the VALIANT trial

    Article • Heart Rhythm, March 2006, Elsevier

    Professor john j mcmurray

  627. Mapping the emergence of heart disease in a black, urban population in Africa: The Heart of Soweto Study

    Article • International Journal of Cardiology, March 2006, Elsevier

    Professor john j mcmurray

  628. Clinical Correlates and Consequences of Anemia in a Broad Spectrum of Patients With Heart Failure: Results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program

    Article • Circulation, February 2006, Wolters Kluwer Health

    Professor john j mcmurray

  629. Beta-blockers and heart failure in older people: reply

    Article • European Heart Journal, February 2006, European Society of Cardiology

    Professor john j mcmurray

  630. Renal Function as a Predictor of Outcome in a Broad Spectrum of Patients With Heart Failure

    Article • Circulation, February 2006, Wolters Kluwer Health

    Professor john j mcmurray

  631. Drug Safety in Cardiovascular Disease: A Call to ACTION

    Article • Cardiovascular Drugs and Therapy, February 2006, Springer Science + Business Media

    Professor john j mcmurray

  632. The Effect of Valsartan, Captopril, or Both on Atherosclerotic Events After Acute Myocardial Infarction

    Article • Journal of the American College of Cardiology, February 2006, Elsevier

    Professor john j mcmurray

  633. The cost of acute myocardial infarction in the new millennium: Evidence from a multinational registry

    Article • American Heart Journal, January 2006, Elsevier

    Professor john j mcmurray

  634. Influence of Ejection Fraction on Cardiovascular Outcomes in a Broad Spectrum of Heart Failure Patients

    Article • Circulation, December 2005, Wolters Kluwer Health

    Professor john j mcmurray

  635. Over 20 000 avoidable coronary deaths in England and Wales in 2000: the failure to give effective treatments to many eligible patients

    Article • Heart, December 2005, BMJ

    Professor john j mcmurray

  636. Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial

    Article • The Lancet, December 2005, Elsevier

    Professor john j mcmurray

  637. Mortality and Morbidity Remain High Despite Captopril and/or Valsartan Therapy in Elderly Patients With Left Ventricular Systolic Dysfunction, Heart Failure, or Both After Acute Myocardial Infarction: Results From the Valsartan in Acute Myocardial Infa...

    Article • Circulation, November 2005, Wolters Kluwer Health

    Professor john j mcmurray

  638. Resource utilization and costs in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme

    Article • European Heart Journal, October 2005, European Society of Cardiology

    Professor john j mcmurray

  639. Impact of Candesartan on Nonfatal Myocardial Infarction and Cardiovascular Death in Patients With Heart Failure

    Article • JAMA, October 2005, American Medical Association (AMA)

    Professor john j mcmurray

  640. Predictors of mortality and morbidity in patients with chronic heart failure

    Article • European Heart Journal, October 2005, European Society of Cardiology

    Professor john j mcmurray

  641. Chronic kidney disease in patients with cardiac disease: A review of evidence-based treatment

    Article • Kidney International, October 2005, Elsevier

    Professor john j mcmurray

  642. A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): Study design and baseline characteristics

    Article • European Journal of Heart Failure, October 2005, Wiley

    Professor john j mcmurray

  643. The Irbesartan in Heart Failure With Preserved Systolic Function (I-PRESERVE) Trial: Rationale and Design

    Article • Journal of Cardiac Failure, October 2005, Elsevier

    Professor john j mcmurray

  644. The role of angiotensin II receptor blockers in the management of heart failure

    Article • European Heart Journal Supplements, October 2005, Oxford University Press (OUP)

    Professor john j mcmurray

  645. Long-term cardiovascular consequences of obesity: 20-year follow-up of more than 15 000 middle-aged men and women (the Renfrew–Paisley study)

    Article • European Heart Journal, September 2005, European Society of Cardiology

    Professor john j mcmurray

  646. Public awareness of heart failure in Europe: first results from SHAPE

    Article • European Heart Journal, August 2005, European Society of Cardiology

    Professor john j mcmurray

  647. Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT)

    Article • American Heart Journal, August 2005, Elsevier

    Professor john j mcmurray

  648. Aspirin Inhibits the Acute Arterial and Venous Vasodilator Response to Captopril in Patients with Chronic Heart Failure

    Article • Cardiovascular Drugs and Therapy, August 2005, Springer Science + Business Media

    Professor john j mcmurray

  649. Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: Putting guidelines into practice

    Article • European Journal of Heart Failure, August 2005, Wiley

    Professor john j mcmurray

  650. Tezosentan in patients with acute heart failure: Design of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Study (VERITAS)

    Article • American Heart Journal, July 2005, Elsevier

    Professor john j mcmurray, Professor John GF Cleland

  651. Heart failure with preserved left ventricular systolic function: a hospital cohort study

    Article • Heart, July 2005, BMJ

    Professor john j mcmurray

  652. Effects of Candesartan on the Development of a New Diagnosis of Diabetes Mellitus in Patients With Heart Failure

    Article • Circulation, June 2005, Wolters Kluwer Health

    Professor john j mcmurray

  653. Cardiovascular Risk Associated with Celecoxib

    Article • New England Journal of Medicine, June 2005, New England Journal of Medicine (NEJM/MMS)

    Professor john j mcmurray

  654. Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both

    Article • New England Journal of Medicine, June 2005, New England Journal of Medicine (NEJM/MMS)

    Professor john j mcmurray

  655. Heart failure on admission and the risk of stroke following acute myocardial infarction: the VALIANT registry

    Article • European Heart Journal, June 2005, European Society of Cardiology

    Professor john j mcmurray

  656. Changes in Ventricular Size and Function in Patients Treated With Valsartan, Captopril, or Both After Myocardial Infarction

    Article • Circulation, June 2005, Wolters Kluwer Health

    Professor john j mcmurray

  657. Heart Failure Management Programs Reduce Readmissions and Prolong Survival

    Article • Archives of Internal Medicine, June 2005, American Medical Association (AMA)

    Professor john j mcmurray

  658. Review: Optimising the use of Angiotensin Receptor Blockers in the Management of Chronic Heart Failure

    Article • Journal of the Renin-Angiotensin-Aldosterone System, June 2005, SAGE Publications

    Professor john j mcmurray

  659. Reduced between-hospital variation in short term survival after acute myocardial infarction: the result of improved cardiac care?

    Article • Heart, June 2005, BMJ

    Professor john j mcmurray

  660. Patient perception of the effect of treatment with candesartan in heart failure. Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme

    Article • European Journal of Heart Failure, May 2005, Wiley

    Professor john j mcmurray

  661. Heart failure

    Article • The Lancet, May 2005, Elsevier

    Professor john j mcmurray

  662. Economic factors associated with antithrombotic treatments for stroke prevention in patients with atrial fibrillation

    Article • European Heart Journal Supplements, May 2005, Oxford University Press (OUP)

    Professor john j mcmurray

  663. Neurohumoral Pathways in Heart Failure With Preserved Systolic Function

    Article • Progress in Cardiovascular Diseases, May 2005, Elsevier

    Professor john j mcmurray

  664. Treatments that improve outcome in the patient with heart failure, left ventricular systolic dysfunction, or both after acute myocardial infarction

    Article • Heart, May 2005, BMJ

    Professor john j mcmurray

  665. Low pulse pressure is independently related to elevated natriuretic peptides and increased mortality in advanced chronic heart failure

    Article • European Heart Journal, April 2005, European Society of Cardiology

    Professor john j mcmurray

  666. Carvedilol reduces the costs of medical care in severe heart failure: An economic analysis of the COPERNICUS study applied to the United Kingdom

    Article • International Journal of Cardiology, April 2005, Elsevier

    Professor john j mcmurray

  667. Heart failure and statins—Why do we need a clinical trial?

    Article • Zeitschrift für Kardiologie, April 2005, Springer Science + Business Media

    Professor john j mcmurray

  668. Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention

    Article • New England Journal of Medicine, March 2005, New England Journal of Medicine (NEJM/MMS)

    Professor john j mcmurray

  669. Rationale—Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): Evolving the management of cardiovascular risk in patients with chronic kidney disease

    Article • American Heart Journal, March 2005, Elsevier

    Professor john j mcmurray

  670. Val-HeFT: do angiotensin-receptor blockers benefit heart failure patients already receiving ACE inhibitor therapy?

    Article • Nature Clinical Practice Cardiovascular Medicine, March 2005, Nature

    Professor john j mcmurray

  671. Ximelagatran Compared with Warfarin for the Prevention of Systemic Embolism and Stroke. An Imputed Placebo Analysis

    Article • Cardiovascular Drugs and Therapy, March 2005, Springer Science + Business Media

    Professor john j mcmurray

  672. How much responsibility should heart failure nurses take?

    Article • European Journal of Heart Failure, February 2005, Wiley

    Professor john j mcmurray

  673. Antiarrhythmic effect of carvedilol after acute myocardial infarction

    Article • Journal of the American College of Cardiology, February 2005, Elsevier

    Professor john j mcmurray

  674. Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study

    Article • Journal of Cardiac Failure, February 2005, Elsevier

    Professor john j mcmurray

  675. Myocardial metabolic manipulation: a new therapeutic approach in heart failure?

    Article • Heart, February 2005, BMJ

    Professor john j mcmurray

  676. Chronic Renal Disease and Cardiovascular Risk

    Article • New England Journal of Medicine, January 2005, New England Journal of Medicine (NEJM/MMS)

    Professor john j mcmurray

  677. Making sense of SENIORS

    Article • European Heart Journal, January 2005, European Society of Cardiology

    Professor john j mcmurray

  678. Optimising the use of Angiotensin Receptor Blockers in the Management of Chronic Heart Failure

    Article • Journal of the Renin-Angiotensin-Aldosterone System, January 2005, SAGE Publications

    Professor john j mcmurray

  679. Documento de Consenso de Expertos sobre bloqueadores de los receptores ß-adrenérgicos

    Article • Revista Española de Cardiología, January 2005, Elsevier

    Professor john j mcmurray

  680. The year in heart failure

    Article • Journal of the American College of Cardiology, December 2004, Elsevier

    Professor john j mcmurray

  681. Anemia and heart failure

    Article • Current Heart Failure Reports, December 2004, Springer Science + Business Media

    Professor john j mcmurray

  682. Documento de Consenso de Expertos sobre el uso de inhibidores de la enzima de conversión de la angiotensina en la enfermedad cardiovascular

    Article • Revista Española de Cardiología, December 2004, Elsevier

    Professor john j mcmurray

  683. Inhibition of late (sustained/ persistent) sodium current: a potential drug target to reduce intracellular sodium-dependent calcium overload and its detrimental effects on cardiomyocyte function

    Article • European Heart Journal Supplements, December 2004, Elsevier

    Professor john j mcmurray

  684. Which Inhibitor of the Renin-Angiotensin System Should Be Used in Chronic Heart Failure and Acute Myocardial Infarction?

    Article • Circulation, November 2004, Wolters Kluwer Health

    Professor john j mcmurray

  685. Effect of candesartan on New York Heart Association functional classResults of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme

    Article • European Heart Journal, November 2004, European Society of Cardiology

    Professor john j mcmurray

  686. An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry

    Article • European Heart Journal, November 2004, European Society of Cardiology

    Professor john j mcmurray

  687. Seasonal variation in morbidity and mortality related to atrial fibrillation

    Article • International Journal of Cardiology, November 2004, Elsevier

    Professor john j mcmurray

  688. Mortality and Morbidity Reduction With Candesartan in Patients With Chronic Heart Failure and Left Ventricular Systolic Dysfunction: Results of the CHARM Low-Left Ventricular Ejection Fraction Trials

    Article • Circulation, October 2004, Wolters Kluwer Health

    Professor john j mcmurray

  689. Effect of Candesartan on Cause-Specific Mortality in Heart Failure Patients: The Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) Program

    Article • Circulation, October 2004, Wolters Kluwer Health

    Professor john j mcmurray

  690. National survey of the prevalence, incidence, primary care burden, and treatment of heart failure in Scotland

    Article • Heart, October 2004, BMJ

    Professor john j mcmurray, Professor Colin R Simpson

  691. Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction

    Article • New England Journal of Medicine, September 2004, New England Journal of Medicine (NEJM/MMS)

    Professor john j mcmurray

  692. Newly Diagnosed and Previously Known Diabetes Mellitus and 1-Year Outcomes of Acute Myocardial Infarction: The Valsartan in Acute Myocardial Infarction (VALIANT) Trial

    Article • Circulation, September 2004, Wolters Kluwer Health

    Professor john j mcmurray

  693. The clinical relevance of adrenomedullin: a promising profile?

    Article • Pharmacology & Therapeutics, September 2004, Elsevier

    Professor john j mcmurray

  694. Treatment of Heart Failure with Spironolactone — Trial and Tribulations

    Article • New England Journal of Medicine, August 2004, New England Journal of Medicine (NEJM/MMS)

    Professor john j mcmurray

  695. Multidisciplinary strategies for the management of heart failure patients at high risk for admission

    Article • Journal of the American College of Cardiology, August 2004, Elsevier

    Professor john j mcmurray

  696. Discharge rates for suspected acute coronary syndromes: Authors' reply

    Article • BMJ, July 2004, BMJ

    Professor john j mcmurray

  697. Anemia and Its Relationship to Clinical Outcome in Heart Failure

    Article • Circulation, July 2004, Wolters Kluwer Health

    Professor john j mcmurray

  698. Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial

    Article • The Lancet, July 2004, Elsevier

    Professor john j mcmurray

  699. Influence of socioeconomic deprivation on the primary care burden and treatment of patients with a diagnosis of heart failure in general practice in Scotland: population based study

    Article • BMJ, April 2004, BMJ

    Professor john j mcmurray, Professor Colin R Simpson

  700. Digitalis for treatment of heart failure in patients in sinus rhythm

    Article • April 2004, Wiley

    Professor john j mcmurray

  701. Targeted Anticytokine Therapy in Patients With Chronic Heart Failure: Results of the Randomized Etanercept Worldwide Evaluation (RENEWAL)

    Article • Circulation, April 2004, Wolters Kluwer Health

    Professor john j mcmurray

  702. Digitalis for treatment of congestive heart failure in patients in sinus rhythm: a systematic review and meta-analysis

    Article • Journal of Cardiac Failure, April 2004, Elsevier

    Professor john j mcmurray

  703. Angiotensin receptor blockers and heart failure: still CHARMing after VALIANT?

    Article • European Heart Journal, March 2004, European Society of Cardiology

    Professor john j mcmurray

  704. Commentary

    Article • Evidence-based Cardiovascular Medicine, March 2004, Elsevier

    Professor john j mcmurray

  705. 1069-116 Prevalence and importance of renal dysfunction in hospitalized heart failure patients

    Article • Journal of the American College of Cardiology, March 2004, Elsevier

    Professor john j mcmurray

  706. Candesartan reduced mortality and hospital admissions in chronic heart failure

    Article • Evidence-Based Medicine, March 2004, BMJ

    Professor john j mcmurray

  707. Increasing Awareness and Perception of Heart Failure in Europe and Improving Care—Rationale and Design of the SHAPE Study

    Article • Cardiovascular Drugs and Therapy, March 2004, Springer Science + Business Media

    Professor john j mcmurray

  708. Early Malignant Progression of Hereditary Medullary Thyroid Cancer

    Article • New England Journal of Medicine, February 2004, New England Journal of Medicine (NEJM/MMS)

    Professor john j mcmurray

  709. What are the clinical consequences of anemia in patients with chronic heart failure?

    Article • Journal of Cardiac Failure, February 2004, Elsevier

    Professor john j mcmurray

  710. Heart failure with preserved left ventricular systolic function

    Article • Journal of the American College of Cardiology, February 2004, Elsevier

    Professor john j mcmurray

  711. Clinical assessment and investigation of patients with suspected heart failure

    Article • January 2004, Informa Healthcare

    Professor john j mcmurray

  712. Heart failure

    Article • January 2004, Informa Healthcare

    Professor john j mcmurray

  713. Angiotensin inhibition in heart failure.

    Article • Journal of the Renin-Angiotensin-Aldosterone System, January 2004, SAGE Publications

    Professor john j mcmurray

  714. 17ß Oestradiol Does Not Attenuate the Response to Angiotensin I and II During Long Term Therapy in Postmenopausal Women

    Article • Cardiovascular Drugs and Therapy, January 2004, Springer Science + Business Media

    Professor john j mcmurray

  715. Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both

    Article • New England Journal of Medicine, November 2003, New England Journal of Medicine (NEJM/MMS)

    Professor john j mcmurray, Professor Raffaele Bugiardini, Professor Thomas Munzel or Muenzel

  716. The statin wars

    Article • The Lancet, November 2003, Elsevier

    Professor john j mcmurray

  717. The CHARM programme

    Article • The Lancet, November 2003, Elsevier

    Professor john j mcmurray

  718. The CHARM programme

    Article • The Lancet, November 2003, Elsevier

    Professor john j mcmurray, Professor John GF Cleland

  719. Heart Failure Updates

    Article • September 2003, Taylor & Francis

    Professor john j mcmurray

  720. Angiotensin receptor blockers in heart failure

    Article • Journal of the Renin-Angiotensin-Aldosterone System, September 2003, SAGE Publications

    Professor john j mcmurray

  721. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

    Article • The Lancet, September 2003, Elsevier

    Professor john j mcmurray

  722. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

    Article • The Lancet, September 2003, Elsevier

    Professor john j mcmurray

  723. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

    Article • The Lancet, September 2003, Elsevier

    Professor john j mcmurray

  724. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

    Article • The Lancet, September 2003, Elsevier

    Professor john j mcmurray

  725. The rise and fall of myotrophin in heart failure**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology.

    Article • Journal of the American College of Cardiology, August 2003, Elsevier

    Professor john j mcmurray

  726. VALsartan In Acute myocardial iNfarcTion (VALIANT) trial: baseline characteristics in context

    Article • European Journal of Heart Failure, August 2003, Wiley

    Professor john j mcmurray

  727. Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) programme

    Article • European Journal of Heart Failure, June 2003, Wiley

    Professor john j mcmurray

  728. It cannot be cardiac failure because the heart is not enlarged on the chest X-ray

    Article • European Journal of Heart Failure, March 2003, Wiley

    Professor john j mcmurray

  729. Seasonal variation in heart failure-related morbidity and mortality

    Article • Heart Lung and Circulation, January 2003, Wiley

    Professor john j mcmurray

  730. Heart failure and the ageing population: An increasing burden in the 21st century?

    Article • Heart Lung and Circulation, January 2003, Wiley

    Professor john j mcmurray

  731. Digitalis zur Behandlung der chronischen Herzinsuffizienz bei Patienten mit Sinusrhythmus

    Article • Praxis, November 2002, Hogrefe Publishing Group

    Professor john j mcmurray

  732. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study

    Article • The American Journal of Medicine, October 2002, Elsevier

    Professor john j mcmurray

  733. An economic analysis of specialist heart failure nurse management in the U.K. Can we afford not to implement it?

    Article • European Heart Journal, September 2002, European Society of Cardiology

    Professor john j mcmurray

  734. Comparison of Omapatrilat and Enalapril in Patients With Chronic Heart Failure: The Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE)

    Article • Circulation, July 2002, Wolters Kluwer Health

    Professor john j mcmurray

  735. Amlodipine for all undergoing PCI? The evidence is unconvincing

    Article • International Journal of Cardiology, July 2002, Elsevier

    Professor john j mcmurray

  736. Is the Pregnancy Hormone Relaxin Also a Vasodilator Peptide Secreted by the Heart?

    Article • Circulation, June 2002, Wolters Kluwer Health

    Professor john j mcmurray

  737. Myocardial Infarct: No One Size Fits All

    Article • Circulation, June 2002, Wolters Kluwer Health

    Professor john j mcmurray

  738. The current cost of heart failure to the National Health Service in the UK

    Article • European Journal of Heart Failure, June 2002, Wiley

    Professor john j mcmurray

  739. New Therapeutic Options in Congestive Heart Failure: Part II

    Article • Circulation, May 2002, Wolters Kluwer Health

    Professor john j mcmurray

  740. Statins and chronic heart failure: do we need a large-scale outcome trial?

    Article • Journal of the American College of Cardiology, May 2002, Elsevier

    Professor john j mcmurray

  741. New Therapeutic Options in Congestive Heart Failure: Part I

    Article • Circulation, April 2002, Wolters Kluwer Health

    Professor john j mcmurray

  742. Substantial between-hospital variation in outcome following first emergency admission for heart failure

    Article • European Heart Journal, April 2002, European Society of Cardiology

    Professor john j mcmurray

  743. Heart failure in a cold climate

    Article • Journal of the American College of Cardiology, March 2002, Elsevier

    Professor john j mcmurray

  744. Trends in case-fatality in 22 968 patients admitted for the first time with atrial fibrillation in Scotland, 1986–1995

    Article • International Journal of Cardiology, March 2002, Elsevier

    Professor john j mcmurray

  745. EARTH: EndothelinA Receptor Antagonist Trial in Heart Failure

    Article • Heart Drug, February 2002, Karger Publishers

    Professor john j mcmurray

  746. Effect of aspirin on vasodilation to bradykinin and substance P in patients with heart failure treated with ACE inhibitor

    Article • British Journal of Clinical Pharmacology, January 2002, Wiley

    Professor john j mcmurray

  747. Cost effectiveness of invasive strategy in unstable coronary disease—what are we waiting for?

    Article • European Heart Journal, January 2002, European Society of Cardiology

    Professor john j mcmurray

  748. Cost-effectiveness of statins in primary and secondary prevention of coronary heart disease

    Article • January 2002, Springer Science + Business Media

    Professor john j mcmurray

  749. The acute vascular effects of frusemide in heart failure

    Article • British Journal of Clinical Pharmacology, December 2001, Wiley

    Professor john j mcmurray

  750. Effects of adrenomedullin on angiotensin II stimulated atrial natriuretic peptide and arginine vasopressin secretion
in healthy humans

    Article • British Journal of Clinical Pharmacology, December 2001, Wiley

    Professor john j mcmurray

  751. Failing ageing hearts

    Article • European Heart Journal, November 2001, European Society of Cardiology

    Professor john j mcmurray

  752. Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone

    Article • The American Journal of Medicine, November 2001, Elsevier

    Professor john j mcmurray

  753. Electrical cardioversion for atrial fibrillation: outcomes in ‘real-life’ clinical practice

    Article • International Journal of Cardiology, November 2001, Elsevier

    Professor john j mcmurray

  754. Age, sex, and social trends in out-of-hospital cardiac deaths in Scotland 1986–95: a retrospective cohort study

    Article • The Lancet, October 2001, Elsevier

    Professor john j mcmurray

  755. Impaired endothelial function in isolated human uremic resistance arteries

    Article • Kidney International, September 2001, Elsevier

    Professor john j mcmurray

  756. Gender and survival: a population-based study of 201,114 men and women following a first acute myocardial infarction

    Article • Journal of the American College of Cardiology, September 2001, Elsevier

    Professor john j mcmurray

  757. Changes in notions about heart failure

    Article • The Lancet, August 2001, Elsevier

    Professor john j mcmurray

  758. Older and more complicated heart failure patients: an increasing challenge to the health care system!

    Article • Coronary Health Care, August 2001, Elsevier

    Professor john j mcmurray

  759. Practical recommendations for the use of ACE inhibitors, beta-blockers and spironolactone in heart failure: putting guidelines into practice

    Article • European Journal of Heart Failure, August 2001, Wiley

    Professor john j mcmurray

  760. Effect of adrenomedullin on the production of endothelin-1 and on its vasoconstrictor action in resistance arteries: evidence for a receptor-specific functional interaction in patients with heart failure

    Article • Clinical Science, July 2001, Portland Press Ltd.

    Professor john j mcmurray

  761. Reduced costs with bisoprolol treatment for heart failure; an economic analysis of the second Cardiac Insufficiency Bisoprolol Study (CIBIS-II)

    Article • European Heart Journal, June 2001, European Society of Cardiology

    Professor john j mcmurray

  762. Economics of chronic heart failure

    Article • European Journal of Heart Failure, June 2001, Wiley

    Professor john j mcmurray

  763. More ‘malignant’ than cancer? Five-year survival following a first admission for heart failure

    Article • European Journal of Heart Failure, June 2001, Wiley

    Professor john j mcmurray

  764. ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: Hemodynamic and neurohormonal effects

    Article • American Heart Journal, May 2001, Elsevier

    Professor john j mcmurray

  765. Trends in hospital activity, morbidity and case fatality related to atrial fibrillation in Scotland, 1986–1996

    Article • European Heart Journal, April 2001, European Society of Cardiology

    Professor john j mcmurray

  766. Aspirin inhibits the acute venodilator response to furosemide in patients with chronic heart failure

    Article • Journal of the American College of Cardiology, April 2001, Elsevier

    Professor john j mcmurray

  767. Attenuation of endothelin-1 induced vasoconstriction by 17β estradiol is not sustained during long-term therapy in postmenopausal women with coronary heart disease

    Article • Journal of the American College of Cardiology, April 2001, Elsevier

    Professor john j mcmurray

  768. Signalling mechanisms underlying the myogenic response in human subcutaneous resistance arteries

    Article • Cardiovascular Research, March 2001, European Society of Cardiology

    Professor john j mcmurray

  769. Altered diaphragm position and function in patients with chronic heart failure

    Article • European Journal of Heart Failure, March 2001, Wiley

    Professor john j mcmurray

  770. Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease

    Article • Journal of the American College of Cardiology, March 2001, Elsevier

    Professor john j mcmurray

  771. Are angiotensin ii receptor blockers more efficacious than placebo in heart failure? implications of elite-2

    Article • The American Journal of Cardiology, March 2001, Elsevier

    Professor john j mcmurray

  772. Poles apart, but are they the same? A comparative study of Australian and Scottish patients with chronic heart failure

    Article • European Journal of Heart Failure, March 2001, Wiley

    Professor john j mcmurray

  773. Trends in hospitalization for heart failure in Scotland, 1990–1996. An epidemic that has reached its peak?

    Article • European Heart Journal, February 2001, European Society of Cardiology

    Professor john j mcmurray

  774. Endothelin Receptor Antagonists and Cardiovascular Diseases of Aging

    Article • Drugs & Aging, January 2001, Springer Science + Business Media

    Professor john j mcmurray

  775. Article • Heart Failure Reviews, January 2001, Springer Science + Business Media

    Professor john j mcmurray

  776. Valsartan in Acute Myocardial Infarction Trial (VALIANT): Rationale and design

    Article • American Heart Journal, November 2000, Elsevier

    Professor john j mcmurray

  777. Acute heart failure: a practical guide to management

    Article • Hospital Medicine, October 2000, Mark Allen Group

    Professor john j mcmurray

  778. Sex-related differences in the use and adverse effects of angiotensin-converting enzyme inhibitors in heart failure: the study of patients intolerant of converting enzyme inhibitors registry

    Article • The American Journal of Medicine, October 2000, Elsevier

    Professor john j mcmurray

  779. Anticoagulation for patients with atrial fibrillation

    Article • BMJ, September 2000, BMJ

    Professor john j mcmurray

  780. Beta-blockers, ventricular arrhythmias, and sudden death in heart failure: not as simple as it seems

    Article • European Heart Journal, August 2000, European Society of Cardiology

    Professor john j mcmurray

  781. Endothelin receptor antagonism in patients with chronic heart failure

    Article • Cardiovascular Research, July 2000, European Society of Cardiology

    Professor john j mcmurray, Dr Anthony P Davenport

  782. Heart failure: we need more trials in typical patients

    Article • European Heart Journal, May 2000, European Society of Cardiology

    Professor john j mcmurray

  783. Endothelial dysfunction in renal transplant recipients maintained on cyclosporine

    Article • Kidney International, March 2000, Elsevier

    Professor john j mcmurray

  784. Digoxin and heart failure

    Article • The Lancet, January 2000, Elsevier

    Professor john j mcmurray

  785. Venous endothelin receptor function in patients with chronic heart failure

    Article • Clinical Science, January 2000, Portland Press Ltd.

    Professor john j mcmurray

  786. Venous endothelin receptor function in patients with chronic heart failure

    Article • Clinical Science, January 2000, Portland Press Ltd.

    Professor john j mcmurray

  787. Candesartan in Heart Failure - Assessment of Reduction in Mortality and Morbidity (CHARM) Study Programme

    Article • Blood Pressure, January 2000, Taylor & Francis

    Professor john j mcmurray

  788. Elevated serum and monocyte tumour necrosis factor alpha in patients with congestive heart failure

    Article • International Journal of Cardiology, December 1999, Elsevier

    Professor john j mcmurray

  789. Cardiac cachexia—lean and mean

    Article • European Heart Journal, November 1999, European Society of Cardiology

    Professor john j mcmurray

  790. A Comparison of the Reproducibility and the Sensitivity to Change of Visual Analogue Scales, Borg Scales, and Likert Scales in Normal Subjects During Submaximal Exercise

    Article • CHEST Journal, November 1999, Elsevier

    Professor john j mcmurray

  791. Increasing the impact of cardiological treatments. How best to reduce deaths

    Article • European Heart Journal, October 1999, European Society of Cardiology

    Professor john j mcmurray

  792. Heart Failure Management

    Article • September 1999, Taylor & Francis

    Professor john j mcmurray

  793. Candesartan in heart failure—assessment of reduction in mortality and morbidity (CHARM): Rationale and design

    Article • Journal of Cardiac Failure, September 1999, Elsevier

    Professor john j mcmurray

  794. Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry

    Article • European Heart Journal, August 1999, European Society of Cardiology

    Professor john j mcmurray

  795. Effects of resistive breathing on exercise capacity and diaphragm function in patients with ischaemic heart disease

    Article • European Journal of Heart Failure, August 1999, Wiley

    Professor john j mcmurray

  796. Transmyocardial laser re vascularisation

    Article • The Lancet, May 1999, Elsevier

    Professor john j mcmurray

  797. Letters to the Editor

    Article • European Heart Journal, March 1999, European Society of Cardiology

    Professor john j mcmurray

  798. Prescribing and emergency admissions for heart failure in greater glasgow

    Article • Journal of Cardiac Failure, March 1999, Elsevier

    Professor john j mcmurray

  799. Vesnarinone was associated with a dose-dependent increase in mortality among patients with severe heart failure

    Article • Evidence-based Cardiovascular Medicine, March 1999, Elsevier

    Professor john j mcmurray

  800. EndothelinBreceptors are functionally important in mediating vasoconstriction in the systemic circulation in patients with left ventricular systolic dysfunction

    Article • Journal of the American College of Cardiology, March 1999, Elsevier

    Professor john j mcmurray, Professor John GF Cleland

  801. Placebo-controlled comparison of candoxatril, an orally active neutral endopeptidase inhibitor, and captopril in patients with chronic heart failure

    Article • European Journal of Heart Failure, March 1999, Wiley

    Professor john j mcmurray

  802. Novel neuropeptides in the pathophysiology of heart failure: adrenomedullin and endothelin-1

    Article • European Journal of Heart Failure, March 1999, Wiley

    Professor john j mcmurray

  803. Communicating risk reductions

    Article • BMJ, February 1999, BMJ

    Professor john j mcmurray

  804. Impaired vascular responsiveness to nitric oxide in renal transplant recipients

    Article • Transplantation Proceedings, February 1999, Elsevier

    Professor john j mcmurray

  805. A Review of Quality-of-Life Evaluations in Patients with Congestive Heart Failure

    Article • PharmacoEconomics, January 1999, Springer Science + Business Media

    Professor john j mcmurray

  806. Final Consensus Statement of the Royal College of Physicians of Edinburgh Consensus Conference on Atrial Fibrillation in Hospital and General Practice, 3-4 September 1998

    Article • British Journal of Haematology, January 1999, Wiley

    Professor john j mcmurray

  807. Importance of heart failure as a cause of death. Changing contribution to overall mortality and coronary heart disease mortality in Scotland 1979–1992

    Article • European Heart Journal, December 1998, European Society of Cardiology

    Professor john j mcmurray

  808. HEART FAILURE A symposium organised as part of the meeting of the British Pharmacological Society held at the Chester Moat House from 21–24 April 1998, hosted by the Department of Pharmacology and Therapeutics, University of Liverpool, and Zeneca Pharm...

    Article • British Journal of Clinical Pharmacology, October 1998, Wiley

    Professor john j mcmurray

  809. Endothelin-1 has haemodynamic effects at pathophysiological concentrations in patients with left ventricular dysfunction

    Article • Cardiovascular Research, September 1998, European Society of Cardiology

    Professor john j mcmurray, Professor John GF Cleland

  810. Short-term haemodynamic effects of BQ-123, a selective endothelin ETA-receptor antagonist, in chronic heart failure

    Article • The Lancet, July 1998, Elsevier

    Professor john j mcmurray

  811. Clinical outcome with enalapril in symptomatic chronic heart failure; a dose comparison

    Article • European Heart Journal, March 1998, European Society of Cardiology

    Professor john j mcmurray

  812. The reproducibility of symptoms during a submaximal exercise test in chronic heart failure

    Article • British Journal of Clinical Pharmacology, March 1998, Wiley

    Professor john j mcmurray

  813. Pulmonary and Systemic Responses to Exogenous Endothelin-1 in Patients with Left Ventricular Dysfunction

    Article • Journal of Cardiovascular Pharmacology, January 1998, Wolters Kluwer Health

    Professor john j mcmurray

  814. Biochemical detection of left-ventricular systolic dysfunction

    Article • The Lancet, January 1998, Elsevier

    Professor john j mcmurray

  815. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population

    Article • The Lancet, September 1997, Elsevier

    Professor john j mcmurray

  816. Digoxin for patients with heart failure in sinus rhythm

    Article • The Lancet, August 1997, Elsevier

    Professor john j mcmurray

  817. An Economic Analysis of the Survival and Ventricular Enlargement (SAVE) Study

    Article • PharmacoEconomics, August 1997, Springer Science + Business Media

    Professor john j mcmurray

  818. A 1 H spin echo and 51 V NMR study of the interaction of vanadate with intact erythrocytes

    Article • JBIC Journal of Biological Inorganic Chemistry, April 1997, Springer Science + Business Media

    Professor john j mcmurray

  819. Lipid-Lowering Strategies for the Prevention of Coronary Heart Disease

    Article • Clinical Science, April 1997, Portland Press Ltd.

    Professor john j mcmurray

  820. Calcium-antagonist controversy: the long and short of it?

    Article • The Lancet, March 1997, Elsevier

    Professor john j mcmurray

  821. Analysis of reproducibility of reference lumen quantitation with intravascular ultrasound in stented coronary arteries

    Article • Catheterization and Cardiovascular Diagnosis, January 1997, Wiley

    Professor john j mcmurray

  822. Measurement of brain natriuretic peptide

    Article • The Lancet, December 1996, Elsevier

    Professor john j mcmurray

  823. Study greatly underestimates the cost effectiveness of statin treatment

    Article • BMJ, November 1996, BMJ

    Professor john j mcmurray

  824. Open-access echocardiography

    Article • The Lancet, November 1996, Elsevier

    Professor john j mcmurray

  825. Captopril and Norepinephrine-Induced Hypertrophy and Haemodynamics in Rats

    Article • Journal of Cardiovascular Pharmacology, May 1996, Wolters Kluwer Health

    Professor john j mcmurray

  826. The Pharmacoeconomics of ACE Inhibitors in Chronic Heart Failure

    Article • PharmacoEconomics, March 1996, Springer Science + Business Media

    Professor john j mcmurray

  827. Clinical Trials Report: Cardiovascular & Renal: Ongoing and planned clinical trials in chronic heart failure and left ventricular dysfunction

    Article • Expert Opinion on Investigational Drugs, November 1995, Informa Healthcare

    Professor john j mcmurray, Professor John GF Cleland

  828. Open access echocardiography in management of the heart failure in the community

    Article • ACC Current Journal Review, November 1995, Elsevier

    Professor john j mcmurray

  829. Stents versus angioplasty

    Article • The Lancet, August 1995, Elsevier

    Professor john j mcmurray

  830. Author's reply

    Article • BMJ, July 1995, BMJ

    Professor john j mcmurray

  831. Dosage of angiotensin converting enzyme inhibitors

    Article • BMJ, July 1995, BMJ

    Professor john j mcmurray

  832. Authors' reply

    Article • BMJ, March 1995, BMJ

    Professor john j mcmurray

  833. Authors' reply

    Article • BMJ, February 1995, BMJ

    Professor john j mcmurray

  834. Scandinavian simvastatin study (4S)

    Article • The Lancet, December 1994, Elsevier

    Professor john j mcmurray

  835. Enhanced basal nitric oxide production in heart failure

    Article • The Lancet, September 1994, Elsevier

    Professor john j mcmurray

  836. The assessment of the HO· scavenging action of therapeutic agents

    Article • Journal of Pharmaceutical and Biomedical Analysis, July 1994, Elsevier

    Professor john j mcmurray

  837. Alteration of the erythrocyte glutathione redox balance by N -acetylcysteine, captopril and exogenous glutathione

    Article • FEBS Letters, June 1994, Wiley

    Professor john j mcmurray

  838. Fortnightly Review: Diagnosis and management of heart failure

    Article • BMJ, January 1994, BMJ

    Professor john j mcmurray

  839. ACE Inhibitors after myocardial Infarctlon

    Article • The Lancet, December 1993, Elsevier

    Professor john j mcmurray

  840. Acute effects of captopril on the renal actions of furosemide in patients with chronic heart failure

    Article • American Heart Journal, October 1993, Elsevier

    Professor john j mcmurray

  841. Effects of the xanthine oxidase system on cardiac function in anaesthetised rats

    Article • Free Radical Biology and Medicine, September 1993, Elsevier

    Professor john j mcmurray

  842. ACE inhibitors and myocardial infarction

    Article • The Lancet, February 1993, Elsevier

    Professor john j mcmurray

  843. ACE inhibitors for myocardial infarction and unstable angina

    Article • The Lancet, December 1992, Elsevier

    Professor john j mcmurray

  844. Evidence for oxidative stress in unstable angina

    Article • Heart, November 1992, BMJ

    Professor john j mcmurray

  845. Circulating Endothelin Is Not Extracted by the Pulmonary Circulation in Man

    Article • CHEST Journal, October 1992, Elsevier

    Professor john j mcmurray

  846. A comparison of laryngeal mask airway with tracheal tube for intra-ocular ophthalmic surgery

    Article • Anaesthesia, August 1992, Wiley

    Professor john j mcmurray

  847. The J-curve hypothesis

    Article • The Lancet, February 1992, Elsevier

    Professor john j mcmurray

  848. Angiotensin converting enzyme inhibitors Reply

    Article • Journal of Hypertension, November 1991, Wolters Kluwer Health

    Professor john j mcmurray

  849. Synergism of histidyl dipeptides as antioxidants

    Article • Journal of Molecular and Cellular Cardiology, November 1991, Elsevier

    Professor john j mcmurray

  850. Silent myocardial ischemia: A critical appraisal

    Article • International Journal of Cardiology, October 1991, Elsevier

    Professor john j mcmurray

  851. Effects of xamoterol in acute myocardial infarction: blood pressure, heart rate, arrhythmias and early clinical course

    Article • International Journal of Cardiology, June 1991, Elsevier

    Professor john j mcmurray

  852. Unique cardioprotective potential of angiotensin converting enzyme inhibitors: a hypothesis still to be tested on humans

    Article • Journal of Hypertension, May 1991, Wolters Kluwer Health

    Professor john j mcmurray

  853. ANTIOXIDANT POTENTIAL OF ACE INHIBITORS

    Article • January 1991, Elsevier

    Professor john j mcmurray

  854. Novel exercise protocol suitable for use on a treadmill or a bicycle ergometer.

    Article • Heart, November 1990, BMJ

    Professor john j mcmurray

  855. Neuroendocrine changes post myocardial infarction: Effects of xamoterol

    Article • American Heart Journal, July 1990, Elsevier

    Professor john j mcmurray

  856. Free radical scavenging: A potentially beneficial action of captopril?

    Article • Journal of Molecular and Cellular Cardiology, May 1990, Elsevier

    Professor john j mcmurray

  857. Evidence for enhanced free radical activity in chronic congestive heart failure secondary to coronary artery disease

    Article • The American Journal of Cardiology, May 1990, Elsevier

    Professor john j mcmurray

  858. Diuretics

    Article • January 1990, Springer Science + Business Media

    Professor john j mcmurray

  859. Atrial Natriuretic Factor Attenuates Prostaglandin E2-Stimulated Plasma Renin Activity in Humans

    Article • Journal of Cardiovascular Pharmacology, August 1989, Wolters Kluwer Health

    Professor john j mcmurray

  860. Neurohumoral aspects of heart failure

    Article • Current Opinion in Cardiology, June 1989, Wolters Kluwer Health

    Professor john j mcmurray

  861. Mechanisms of the antinatriuretic action of physiological doses of angiotensin II in man

    Article • Clinical Science, June 1989, Portland Press Ltd.

    Professor john j mcmurray

  862. The Place of Angiotensin-Converting Enzyme Inhibitors in Internal Medicine

    Article • Medical Principles and Practice, January 1989, Karger Publishers

    Professor john j mcmurray

  863. Physiological increases in circulating noradrenaline are antinatriuretic in man

    Article • Journal of Hypertension, September 1988, Wolters Kluwer Health

    Professor john j mcmurray

  864. The place of ACE inhibitors in the current treatment of chronic heart failure.

    Article • Postgraduate Medical Journal, September 1988, BMJ

    Professor john j mcmurray

  865. Heart Failure

    Article • January 1988, Taylor & Francis

    Professor john j mcmurray

  866. Atrial natriuretic factor inhibits ACTH stimulated aldosterone, but not cortisol, secretion in man

    Article • European Journal of Clinical Pharmacology, January 1988, Springer Science + Business Media

    Professor john j mcmurray

  867. Frusemide pretreatment blunts the inhibition of renal tubular sodium reabsorption by ANF in man

    Article • European Journal of Clinical Pharmacology, January 1988, Springer Science + Business Media

    Professor john j mcmurray

  868. Consequences of fluid loss in patients treated with ACE inhibitors.

    Article • Postgraduate Medical Journal, May 1987, BMJ

    Professor john j mcmurray

  869. Reversible renal failure after combined treatment with enalapril and frusemide in a patient with congestive heart failure

    Article • Heart, November 1986, BMJ

    Professor john j mcmurray

  870. Pneumonia.

    Article • Postgraduate Medical Journal, September 1986, BMJ

    Professor john j mcmurray

  871. CAPTOPRIL, ENALAPRIL, AND BLOOD GLUCOSE

    Article • The Lancet, May 1986, Elsevier

    Professor john j mcmurray

  872. EFFECT OF DIARRHOEA ON A PATIENT TAKING CAPTOPRIL

    Article • The Lancet, March 1985, Elsevier

    Professor john j mcmurray

  873. Coronary Heart Disease and Diabetes

    Article • Wiley

    Professor john j mcmurray

  874. Diabetes and Acute Coronary Syndromes

    Article • Wiley

    Professor john j mcmurray

  875. Angiotensin Receptor Blockers for Chronic Heart Failure and Acute Myocardial Infarction

    Article • Taylor & Francis

    Professor john j mcmurray

  876. State of the Art Treatment for Chronic Heart Failure

    Article • Wiley

    Professor john j mcmurray

  877. Diabetes, Left Ventricular Systolic Dysfunction and Chronic Heart Failure

    Article • Wiley

    Professor john j mcmurray